메뉴 건너뛰기




Volumn 2, Issue 22, 2018, Pages 3257-3291

American Society of Hematology 2018 guidelines for management of venous thromboembolism: Optimal management of anticoagulation therapy

(17)  Witt, Daniel M l   Nieuwlaat, Robby a   Clark, Nathan P b   Ansell, Jack c   Holbrook, Anne d   Skov, Jane e   Shehab, Nadine f   Mock, Juliet g   Myers, Tarra h   Dentali, Francesco i   Crowther, Mark A a   Agarwal, Arnav a,j   Bhatt, Meha a   Khatib, Rasha k   Riva, John J a   Zhang, Yuan a   Guyatt, Gordon a  


Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10A ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; CYTOCHROME P450; HEPARIN; VITAMIN K GROUP;

EID: 85057278883     PISSN: 24739529     EISSN: 24739537     Source Type: Journal    
DOI: 10.1182/bloodadvances.2018024893     Document Type: Review
Times cited : (365)

References (235)
  • 1
    • 84954455938 scopus 로고    scopus 로고
    • Pharmacology of anticoagulants used in the treatment of venous thromboembolism
    • published correction J Thromb Thrombolysis. 2016;42(2):296-311
    • Nutescu EA, Burnett A, Fanikos J, Spinler S, Wittkowsky A. Pharmacology of anticoagulants used in the treatment of venous thromboembolism [published correction appears in J Thromb Thrombolysis. 2016;42(2):296-311]. J Thromb Thrombolysis. 2016;41(1):15-31.
    • (2016) J Thromb Thrombolysis , vol.41 , Issue.1 , pp. 15-31
    • Nutescu, E.A.1    Burnett, A.2    Fanikos, J.3    Spinler, S.4    Wittkowsky, A.5
  • 2
    • 84894232568 scopus 로고    scopus 로고
    • Guidelines 2.0: Systematic development of a comprehensive checklist for a successful guideline enterprise
    • Schünemann HJ, Wiercioch W, Etxeandia I, et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ. 2014;186(3):E123-E142.
    • (2014) CMAJ , vol.186 , Issue.3 , pp. E123-E142
    • Schünemann, H.J.1    Wiercioch, W.2    Etxeandia, I.3
  • 3
    • 79955777858 scopus 로고    scopus 로고
    • Institute of Medicine US Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, eds. Washington, DC: National Academies Press
    • Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust. Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, eds. Washington, DC: National Academies Press; 2011.
    • (2011) Clinical Practice Guidelines We Can Trust
  • 4
    • 84859304384 scopus 로고    scopus 로고
    • Guidelines international network: Toward international standards for clinical practice guidelines
    • Board of Trustees of the Guidelines International Network
    • Qaseem A, Forland F, Macbeth F, Ollenschläger G, Phillips S, van der Wees P; Board of Trustees of the Guidelines International Network. Guidelines International Network: toward international standards for clinical practice guidelines. Ann Intern Med. 2012;156(7): 525-531.
    • (2012) Ann Intern Med , vol.156 , Issue.7 , pp. 525-531
    • Qaseem, A.1    Forland, F.2    Macbeth, F.3    Ollenschläger, G.4    Phillips, S.5    Van Der Wees, P.6
  • 5
    • 84943374006 scopus 로고    scopus 로고
    • Guidelines international network: Principles for disclosure of interests and management of conflicts in guidelines
    • Board of Trustees of the Guidelines International Network
    • Schünemann HJ, Al-Ansary LA, Forland F, et al; Board of Trustees of the Guidelines International Network. Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines. Ann Intern Med. 2015;163(7):548-553.
    • (2015) Ann Intern Med , vol.163 , Issue.7 , pp. 548-553
    • Schünemann, H.J.1    Al-Ansary, L.A.2    Forland, F.3
  • 6
    • 84977108887 scopus 로고    scopus 로고
    • GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines
    • Alonso-Coello P, Oxman AD, Moberg J, et al; GRADE Working Group. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ. 2016;353:i2089.
    • (2016) BMJ , vol.353 , pp. i2089
    • Alonso-Coello, P.1    Oxman, A.D.2    Moberg, J.3
  • 7
    • 84977108887 scopus 로고    scopus 로고
    • GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 1: Introduction
    • Alonso-Coello P, Schünemann HJ, Moberg J, et al; GRADE Working Group. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ. 2016;353:i2016.
    • (2016) BMJ , vol.353 , pp. i2016
    • Alonso-Coello, P.1    Schünemann, H.J.2    Moberg, J.3
  • 8
    • 20044382229 scopus 로고    scopus 로고
    • Systems for grading the quality of evidence and the strength of recommendations. I: Critical appraisal of existing approaches
    • Atkins D, Eccles M, Flottorp S, et al; GRADE Working Group. Systems for grading the quality of evidence and the strength of recommendations. I: Critical appraisal of existing approaches. BMC Health Serv Res. 2004;4(1):38.
    • (2004) BMC Health Serv Res , vol.4 , Issue.1 , pp. 38
    • Atkins, D.1    Eccles, M.2    Flottorp, S.3
  • 9
    • 79951952372 scopus 로고    scopus 로고
    • GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
    • Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-394.
    • (2011) J Clin Epidemiol , vol.64 , Issue.4 , pp. 383-394
    • Guyatt, G.1    Oxman, A.D.2    Akl, E.A.3
  • 10
    • 43049113533 scopus 로고    scopus 로고
    • GradE: An emerging consensus on rating quality of evidence and strength of recommendations
    • Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926.
    • (2008) BMJ , vol.336 , Issue.7650 , pp. 924-926
    • Guyatt, G.H.1    Oxman, A.D.2    Vist, G.E.3
  • 11
    • 0142025355 scopus 로고    scopus 로고
    • Letters, numbers, symbols and words: How to communicate grades of evidence and recommendations
    • Schünemann HJ, Best D, Vist G, Oxman AD; GRADE Working Group. Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. CMAJ. 2003;169(7):677-680.
    • (2003) CMAJ , vol.169 , Issue.7 , pp. 677-680
    • Schünemann, H.J.1    Best, D.2    Vist, G.3    Oxman, A.D.4
  • 12
    • 84991666275 scopus 로고    scopus 로고
    • GRADE guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health
    • Schünemann HJ, Mustafa R, Brozek J, et al; GRADE Working Group. GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health. J Clin Epidemiol. 2016;76:89-98.
    • (2016) J Clin Epidemiol , vol.76 , pp. 89-98
    • Schünemann, H.J.1    Mustafa, R.2    Brozek, J.3
  • 13
    • 84856804647 scopus 로고    scopus 로고
    • Parenteral anticoagulants: Antithrombotic therapy and Prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
    • published corrections appear in Chest. 2012;141(5):1369 and Chest. 2013; 144(2):721
    • Garcia DA, Baglin TP, Weitz JI, Samama MM. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [published corrections appear in Chest. 2012;141(5):1369 and Chest. 2013; 144(2):721]. Chest. 2012;141(suppl 2):e24S-e43S.
    • (2012) Chest , vol.141 , pp. e24S-e43S
    • Garcia, D.A.1    Baglin, T.P.2    Weitz, J.I.3    Samama, M.M.4
  • 14
    • 84856797169 scopus 로고    scopus 로고
    • Prevention of VTE in orthopedic surgery patients: Antithrombotic therapy and Prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
    • Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(suppl 2):e278S-e325S.
    • (2012) Chest , vol.141 , pp. e278S-e325S
    • Falck-Ytter, Y.1    Francis, C.W.2    Johanson, N.A.3
  • 15
    • 84856778149 scopus 로고    scopus 로고
    • Prevention of VTE in nonorthopedic surgical patients: Antithrombotic therapy and Prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
    • published correction Chest. 2012;141(5):1369
    • Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [published correction appears in Chest. 2012;141(5):1369]. Chest. 2012;141(suppl 2):e227S-e277S.
    • (2012) Chest , vol.141 , pp. e227S-e277S
    • Gould, M.K.1    Garcia, D.A.2    Wren, S.M.3
  • 16
    • 84856806342 scopus 로고    scopus 로고
    • Prevention of VTE in nonsurgical patients: Antithrombotic therapy and Prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
    • Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(suppl 2):e195S-e226S.
    • (2012) Chest , vol.141 , pp. e195S-e226S
    • Kahn, S.R.1    Lim, W.2    Dunn, A.S.3
  • 18
    • 84908287778 scopus 로고    scopus 로고
    • Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: A descriptive study
    • Akl EA, El-Hachem P, Abou-Haidar H, Neumann I, Schünemann HJ, Guyatt GH. Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: a descriptive study. J Clin Epidemiol. 2014;67(11):1222-1228.
    • (2014) J Clin Epidemiol , vol.67 , Issue.11 , pp. 1222-1228
    • Akl, E.A.1    El-Hachem, P.2    Abou-Haidar, H.3    Neumann, I.4    Schünemann, H.J.5    Guyatt, G.H.6
  • 19
    • 77953466930 scopus 로고    scopus 로고
    • The vexing problem of guidelines and conflict of interest: A potential solution
    • Guyatt G, Akl EA, Hirsh J, et al. The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med. 2010;152(11): 738-741.
    • (2010) Ann Intern Med , vol.152 , Issue.11 , pp. 738-741
    • Guyatt, G.1    Akl, E.A.2    Hirsh, J.3
  • 20
    • 69949093644 scopus 로고    scopus 로고
    • An official American Thoracic Society Policy statement: Managing conflict of interest in professional societies
    • Schünemann HJ, Osborne M, Moss J, et al; ATS Ethics and Conflict of Interest Committee and the Documents Development and Implementation Committee. An official American Thoracic Society Policy statement: managing conflict of interest in professional societies. Am J Respir Crit Care Med. 2009;180(6):564-580.
    • (2009) Am J Respir Crit Care Med , vol.180 , Issue.6 , pp. 564-580
    • Schünemann, H.J.1    Osborne, M.2    Moss, J.3
  • 22
    • 79951951792 scopus 로고    scopus 로고
    • GRADE guidelines: 2. Framing the question and deciding on important outcomes
    • Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4): 395-400.
    • (2011) J Clin Epidemiol , vol.64 , Issue.4 , pp. 395-400
    • Guyatt, G.H.1    Oxman, A.D.2    Kunz, R.3
  • 23
    • 20444461204 scopus 로고    scopus 로고
    • The safety of dosing dalteparin based on actual body weight for the treatment of acute venous thromboembolism in obese patients
    • Al-Yaseen E, Wells PS, Anderson J, Martin J, Kovacs MJ. The safety of dosing dalteparin based on actual body weight for the treatment of acute venous thromboembolism in obese patients. J Thromb Haemost. 2005;3(1):100-102.
    • (2005) J Thromb Haemost , vol.3 , Issue.1 , pp. 100-102
    • Al-Yaseen, E.1    Wells, P.S.2    Anderson, J.3    Martin, J.4    Kovacs, M.J.5
  • 24
    • 84861683369 scopus 로고    scopus 로고
    • A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: Steflux (superficial thromboembolism and fluxum)
    • Cosmi B, Filippini M, Tonti D, et al; STEFLUX Investigators. A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum). J Thromb Haemost. 2012;10(6):1026-1035.
    • (2012) J Thromb Haemost , vol.10 , Issue.6 , pp. 1026-1035
    • Cosmi, B.1    Filippini, M.2    Tonti, D.3
  • 25
    • 84989210994 scopus 로고    scopus 로고
    • Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies
    • Di Nisio M, Vedovati MC, Riera-Mestre A, et al. Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies. Thromb Haemost. 2016;116(4):739-746.
    • (2016) Thromb Haemost , vol.116 , Issue.4 , pp. 739-746
    • Di Nisio, M.1    Vedovati, M.C.2    Riera-Mestre, A.3
  • 26
    • 0037485598 scopus 로고    scopus 로고
    • Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: Analysis from the ESSENCE and TIMI 11B studies
    • Spinler SA, Inverso SM, Cohen M, Goodman SG, Stringer KA, Antman EM; ESSENCE and TIMI 11B Investigators. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies. Am Heart J. 2003;146(1):33-41.
    • (2003) Am Heart J , vol.146 , Issue.1 , pp. 33-41
    • Spinler, S.A.1    Inverso, S.M.2    Cohen, M.3    Goodman, S.G.4    Stringer, K.A.5    Antman, E.M.6
  • 27
    • 0034945986 scopus 로고    scopus 로고
    • Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular-weight heparin for the treatment of venous thromboembolism
    • Wilson SJ, Wilbur K, Burton E, Anderson DR. Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular-weight heparin for the treatment of venous thromboembolism. Haemostasis. 2001;31(1):42-48.
    • (2001) Haemostasis , vol.31 , Issue.1 , pp. 42-48
    • Wilson, S.J.1    Wilbur, K.2    Burton, E.3    Anderson, D.R.4
  • 28
    • 85020869393 scopus 로고    scopus 로고
    • Efficacy and safety of rivaroxaban versus warfarin in patients taking nondihydropyridine calcium channel blockers for atrial fibrillation (from the ROCKET AF Trial)
    • Washam JB, Hellkamp AS, Lokhnygina Y, et al; ROCKET AF Steering Committee and Investigators. Efficacy and safety of rivaroxaban versus warfarin in patients taking nondihydropyridine calcium channel blockers for atrial fibrillation (from the ROCKET AF Trial). Am J Cardiol. 2017;120(4):588-594.
    • (2017) Am J Cardiol , vol.120 , Issue.4 , pp. 588-594
    • Washam, J.B.1    Hellkamp, A.S.2    Lokhnygina, Y.3
  • 30
    • 84855377629 scopus 로고    scopus 로고
    • Results of the first randomized French study evaluating self-testing of the international normalized ratio
    • Azarnoush K, Camilleri L, Aublet-Cuvelier B, et al. Results of the first randomized French study evaluating self-testing of the international normalized ratio. J Heart Valve Dis. 2011;20(5):518-525.
    • (2011) J Heart Valve Dis , vol.20 , Issue.5 , pp. 518-525
    • Azarnoush, K.1    Camilleri, L.2    Aublet-Cuvelier, B.3
  • 31
    • 0034619505 scopus 로고    scopus 로고
    • A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial
    • Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Ann Intern Med. 2000;133(9):687-695.
    • (2000) Ann Intern Med , vol.133 , Issue.9 , pp. 687-695
    • Beyth, R.J.1    Quinn, L.2    Landefeld, C.S.3
  • 33
    • 0344851886 scopus 로고    scopus 로고
    • Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in The Netherlands: A randomized clinical trial
    • Gadisseur AP, Breukink-Engbers WG, van der Meer FJ, van den Besselaar AM, Sturk A, Rosendaal FR. Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in The Netherlands: a randomized clinical trial. Arch Intern Med. 2003;163(21):2639-2646.
    • (2003) Arch Intern Med , vol.163 , Issue.21 , pp. 2639-2646
    • Gadisseur, A.P.1    Breukink-Engbers, W.G.2    Van Der Meer, F.J.3    Van Den Besselaar, A.M.4    Sturk, A.5    Rosendaal, F.R.6
  • 34
    • 0031937723 scopus 로고    scopus 로고
    • Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease
    • Horstkotte D, Piper C, Wiemer M. Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. J Thromb Thrombolysis. 1998;5 suppl 1(3):19-24.
    • (1998) J Thromb Thrombolysis , vol.5 , Issue.3 , pp. 19-24
    • Horstkotte, D.1    Piper, C.2    Wiemer, M.3
  • 35
    • 4143114484 scopus 로고    scopus 로고
    • The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation
    • Khan TI, Kamali F, Kesteven P, Avery P, Wynne H. The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. Br J Haematol. 2004;126(4):557-564.
    • (2004) Br J Haematol , vol.126 , Issue.4 , pp. 557-564
    • Khan, T.I.1    Kamali, F.2    Kesteven, P.3    Avery, P.4    Wynne, H.5
  • 36
    • 77958549170 scopus 로고    scopus 로고
    • Effect of home testing of international normalized ratio on clinical events
    • Matchar DB, Jacobson A, Dolor R, et al; THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. N Engl J Med. 2010;363(17):1608-1620.
    • (2010) N Engl J Med , vol.363 , Issue.17 , pp. 1608-1620
    • Matchar, D.B.1    Jacobson, A.2    Dolor, R.3
  • 37
    • 84865485107 scopus 로고    scopus 로고
    • Effects of computer-assisted oral anticoagulant therapy
    • Rasmussen RS, Corell P, Madsen P, Overgaard K. Effects of computer-assisted oral anticoagulant therapy. Thromb J. 2012;10(1):17.
    • (2012) Thromb J , vol.10 , Issue.1 , pp. 17
    • Rasmussen, R.S.1    Corell, P.2    Madsen, P.3    Overgaard, K.4
  • 38
    • 67949094412 scopus 로고    scopus 로고
    • Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system
    • Ryan F, Byrne S, O'Shea S. Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. J Thromb Haemost. 2009;7(8):1284-1290.
    • (2009) J Thromb Haemost , vol.7 , Issue.8 , pp. 1284-1290
    • Ryan, F.1    Byrne, S.2    O'Shea, S.3
  • 39
    • 84881616330 scopus 로고    scopus 로고
    • Anticoagulation early after mechanical valve replacement: Improved management with patient self-testing
    • Thompson JL, Burkhart HM, Daly RC, et al. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing. J Thorac Cardiovasc Surg. 2013;146(3):599-604.
    • (2013) J Thorac Cardiovasc Surg , vol.146 , Issue.3 , pp. 599-604
    • Thompson, J.L.1    Burkhart, H.M.2    Daly, R.C.3
  • 40
    • 0024415636 scopus 로고
    • Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study
    • White RH, McCurdy SA, von Marensdorff H, Woodruff DE Jr, Leftgoff L. Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Ann Intern Med. 1989;111(9):730-737.
    • (1989) Ann Intern Med , vol.111 , Issue.9 , pp. 730-737
    • White, R.H.1    McCurdy, S.A.2    Von Marensdorff, H.3    Woodruff, D.E.4    Leftgoff, L.5
  • 41
    • 5144227220 scopus 로고    scopus 로고
    • Patient self-management of oral anticoagulant care vs. Management by specialized anticoagulation clinics: Positive effects on quality of life
    • Gadisseur AP, Kaptein AA, Breukink-Engbers WG, van der Meer FJ, Rosendaal FR. Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. J Thromb Haemost. 2004;2(4):584-591.
    • (2004) J Thromb Haemost , vol.2 , Issue.4 , pp. 584-591
    • Gadisseur, A.P.1    Kaptein, A.A.2    Breukink-Engbers, W.G.3    Van Der Meer, F.J.4    Rosendaal, F.R.5
  • 42
    • 84958166689 scopus 로고    scopus 로고
    • The impact of frequency of patient self-testing of prothrombin time on time in target range within VA Cooperative Study #481: The Home INR Study (THINRS), a randomized, controlled trial
    • Matchar DB, Love SR, Jacobson AK, et al. The impact of frequency of patient self-testing of prothrombin time on time in target range within VA Cooperative Study #481: The Home INR Study (THINRS), a randomized, controlled trial. J Thromb Thrombolysis. 2015;40(1):17-25.
    • (2015) J Thromb Thrombolysis , vol.40 , Issue.1 , pp. 17-25
    • Matchar, D.B.1    Love, S.R.2    Jacobson, A.K.3
  • 43
    • 84936133107 scopus 로고    scopus 로고
    • The clinical effectiveness and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/ INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term Vitamin K antagonist therapy, compared with standard UK practice: Systematic review and economic evaluation
    • Sharma P, Scotland G, Cruickshank M, et al. The clinical effectiveness and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/ INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term vitamin K antagonist therapy, compared with standard UK practice: systematic review and economic evaluation. Health Technol Assess. 2015;19(48):1-172.
    • (2015) Health Technol Assess , vol.19 , Issue.48 , pp. 1-172
    • Sharma, P.1    Scotland, G.2    Cruickshank, M.3
  • 44
    • 84970996558 scopus 로고    scopus 로고
    • At-home versus in-clinic INR monitoring: A cost-utility analysis from the Home INR Study (THINRS)
    • Phibbs CS, Love SR, Jacobson AK, et al; writing for the THINRS Executive Committee and Site Investigators. At-home versus in-clinic INR monitoring: a cost-utility analysis from the Home INR Study (THINRS). J Gen Intern Med. 2016;31(9):1061-1067.
    • (2016) J Gen Intern Med , vol.31 , Issue.9 , pp. 1061-1067
    • Phibbs, C.S.1    Love, S.R.2    Jacobson, A.K.3
  • 45
    • 84958581085 scopus 로고    scopus 로고
    • Budget impact of increasing market share of patient self-testing and patient self-management in anticoagulation
    • Stevanović J, Postma MJ, Le HH. Budget impact of increasing market share of patient self-testing and patient self-management in anticoagulation. Value Health. 2016;19(4):383-390.
    • (2016) Value Health , vol.19 , Issue.4 , pp. 383-390
    • Stevanović, J.1    Postma, M.J.2    Le, H.H.3
  • 46
    • 40549117917 scopus 로고    scopus 로고
    • Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: A systematic review and economic modelling
    • ix-66
    • Connock M, Stevens C, Fry-Smith A, et al. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Health Technol Assess. 2007;11(38):iii-iv, ix-66.
    • (2007) Health Technol Assess , vol.11 , Issue.38 , pp. iii-iv
    • Connock, M.1    Stevens, C.2    Fry-Smith, A.3
  • 47
    • 85072746465 scopus 로고    scopus 로고
    • Guidance on the Use of Point-of-Care Testing of International Normalized Ratio for Patients on Oral Anticoagulant Therapy. Ottawa, ON, Canada: Canadian Agency for Drugs and Technologies in Health
    • Guidance on the Use of Point-of-Care Testing of International Normalized Ratio for Patients on Oral Anticoagulant Therapy. CADTH Optimal Use Reports. Ottawa, ON, Canada: Canadian Agency for Drugs and Technologies in Health; 2014.
    • (2014) CADTH Optimal Use Reports
  • 48
    • 84887152957 scopus 로고    scopus 로고
    • Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial
    • Dignan R, Keech AC, Gebski VJ, Mann KP, Hughes CF; Warfarin SMART Investigators. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. Int J Cardiol. 2013;168(6):5378-5384.
    • (2013) Int J Cardiol , vol.168 , Issue.6 , pp. 5378-5384
    • Dignan, R.1    Keech, A.C.2    Gebski, V.J.3    Mann, K.P.4    Hughes, C.F.5
  • 49
    • 58349088527 scopus 로고    scopus 로고
    • Self-management program improves anticoagulation control and quality of life: A prospective randomized study
    • Soliman Hamad MA, van Eekelen E, van Agt T, van Straten AH. Self-management program improves anticoagulation control and quality of life: a prospective randomized study. Eur J Cardiothorac Surg. 2009;35(2):265-269.
    • (2009) Eur J Cardiothorac Surg , vol.35 , Issue.2 , pp. 265-269
    • Soliman Hamad, M.A.1    Van Eekelen, E.2    Van Agt, T.3    Van Straten, A.H.4
  • 50
    • 0036846212 scopus 로고    scopus 로고
    • A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management
    • Fitzmaurice DA, Murray ET, Gee KM, Allan TF, Hobbs FD. A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. J Clin Pathol. 2002;55(11):845-849.
    • (2002) J Clin Pathol , vol.55 , Issue.11 , pp. 845-849
    • Fitzmaurice, D.A.1    Murray, E.T.2    Gee, K.M.3    Allan, T.F.4    Hobbs, F.D.5
  • 51
    • 33947310924 scopus 로고    scopus 로고
    • Self-management of oral anticoagulation in the elderly: Rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial
    • Siebenhofer A, Rakovac I, Kleespies C, Piso B, Didjurgeit U. Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thromb Haemost. 2007;97(3):408-416.
    • (2007) Thromb Haemost , vol.97 , Issue.3 , pp. 408-416
    • Siebenhofer, A.1    Rakovac, I.2    Kleespies, C.3    Piso, B.4    Didjurgeit, U.5
  • 52
    • 84867293256 scopus 로고    scopus 로고
    • Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: A randomized trial
    • Verret L, Couturier J, Rozon A, et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy. 2012;32(10):871-879.
    • (2012) Pharmacotherapy , vol.32 , Issue.10 , pp. 871-879
    • Verret, L.1    Couturier, J.2    Rozon, A.3
  • 53
    • 27744552185 scopus 로고    scopus 로고
    • Self management of oral anticoagulation: Randomised trial
    • Fitzmaurice DA, Murray ET, McCahon D, et al. Self management of oral anticoagulation: randomised trial. BMJ. 2005;331(7524):1057.
    • (2005) BMJ , vol.331 , Issue.7524 , pp. 1057
    • Fitzmaurice, D.A.1    Murray, E.T.2    McCahon, D.3
  • 55
    • 80051709131 scopus 로고    scopus 로고
    • Patient self-management of warfarin therapy: Pragmatic feasibility study in Canadian primary care
    • Grunau BE, Wiens MO, Harder KK. Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Can Fam Physician. 2011;57(8):e292-e298.
    • (2011) Can Fam Physician , vol.57 , Issue.8 , pp. e292-e298
    • Grunau, B.E.1    Wiens, M.O.2    Harder, K.K.3
  • 56
    • 19944430043 scopus 로고    scopus 로고
    • Comparing self-management of oral anticoagulant therapy with clinic management: A randomized trial
    • Menéndez-Jándula B, Souto JC, Oliver A, et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Ann Intern Med. 2005;142(1):1-10.
    • (2005) Ann Intern Med , vol.142 , Issue.1 , pp. 1-10
    • Menéndez-Jándula, B.1    Souto, J.C.2    Oliver, A.3
  • 57
    • 15444365343 scopus 로고    scopus 로고
    • Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study)
    • Völler H, Glatz J, Taborski U, Bernardo A, Dovifat C, Heidinger K. Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Z Kardiol. 2005;94(3):182-186.
    • (2005) Z Kardiol , vol.94 , Issue.3 , pp. 182-186
    • Völler, H.1    Glatz, J.2    Taborski, U.3    Bernardo, A.4    Dovifat, C.5    Heidinger, K.6
  • 58
    • 0034934543 scopus 로고    scopus 로고
    • International normalized ratio self-management after mechanical heart valve replacement: Is an early start advantageous?
    • Körtke H, Körfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg. 2001;72(1):44-48.
    • (2001) Ann Thorac Surg , vol.72 , Issue.1 , pp. 44-48
    • Körtke, H.1    Körfer, R.2
  • 59
    • 0033550473 scopus 로고    scopus 로고
    • A structured teaching and self-management program for patients receiving oral anticoagulation: A randomized controlled trial
    • Sawicki PT; Working Group for the Study of Patient Self-Management of Oral Anticoagulation. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. JAMA. 1999;281(2):145-150.
    • (1999) JAMA , vol.281 , Issue.2 , pp. 145-150
    • Sawicki, P.T.1
  • 60
    • 33744546555 scopus 로고    scopus 로고
    • Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial
    • Christensen TD, Maegaard M, Sørensen HT, Hjortdal VE, Hasenkam JM. Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. Eur J Intern Med. 2006;17(4):260-266.
    • (2006) Eur J Intern Med , vol.17 , Issue.4 , pp. 260-266
    • Christensen, T.D.1    Maegaard, M.2    Sørensen, H.T.3    Hjortdal, V.E.4    Hasenkam, J.M.5
  • 61
    • 0035167657 scopus 로고    scopus 로고
    • Self-managed anticoagulation: Results from a two-year prospective randomized trial with heart valve patients
    • Sidhu P, O'Kane HO. Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Ann Thorac Surg. 2001;72(5):1523-1527.
    • (2001) Ann Thorac Surg , vol.72 , Issue.5 , pp. 1523-1527
    • Sidhu, P.1    O'Kane, H.O.2
  • 62
    • 0034622382 scopus 로고    scopus 로고
    • Oral anticoagulation self-management and management by a specialist anticoagulation clinic: A randomised cross-over comparison
    • Cromheecke ME, Levi M, Colly LP, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet. 2000;356(9224):97-102.
    • (2000) Lancet , vol.356 , Issue.9224 , pp. 97-102
    • Cromheecke, M.E.1    Levi, M.2    Colly, L.P.3
  • 63
    • 0042917969 scopus 로고    scopus 로고
    • INR self-management permits lower anticoagulation levels after mechanical heart valve replacement
    • Koertke H, Minami K, Boethig D, et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation. 2003;108(suppl 1):II75-II78.
    • (2003) Circulation , vol.108 , pp. II75-II78
    • Koertke, H.1    Minami, K.2    Boethig, D.3
  • 64
    • 20444403391 scopus 로고    scopus 로고
    • Low-dose international normalized ratio self-management: A promising tool to achieve low complication rates after mechanical heart valve replacement
    • discussion 14
    • Koertke H, Zittermann A, Minami K, et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Ann Thorac Surg. 2005;79(6):1909-1914; discussion 14.
    • (2005) Ann Thorac Surg , vol.79 , Issue.6 , pp. 1909-1914
    • Koertke, H.1    Zittermann, A.2    Minami, K.3
  • 65
    • 35348983533 scopus 로고    scopus 로고
    • Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: Final report from the early self-management anticoagulation trial II
    • Koertke H, Zittermann A, Tenderich G, et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. Eur Heart J. 2007;28(20):2479-2484.
    • (2007) Eur Heart J , vol.28 , Issue.20 , pp. 2479-2484
    • Koertke, H.1    Zittermann, A.2    Tenderich, G.3
  • 66
    • 78049318957 scopus 로고    scopus 로고
    • Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement
    • Koertke H, Zittermann A, Wagner O, et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Ann Thorac Surg. 2010;90(5):1487-1493.
    • (2010) Ann Thorac Surg , vol.90 , Issue.5 , pp. 1487-1493
    • Koertke, H.1    Zittermann, A.2    Wagner, O.3
  • 67
    • 33845476726 scopus 로고    scopus 로고
    • Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement
    • Koertke H, Zittermann A, Wagner O, Koerfer R. Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Ann Thorac Surg. 2007;83(1):24-29.
    • (2007) Ann Thorac Surg , vol.83 , Issue.1 , pp. 24-29
    • Koertke, H.1    Zittermann, A.2    Wagner, O.3    Koerfer, R.4
  • 68
    • 0035676305 scopus 로고    scopus 로고
    • INR self-management after mechanical heart valve replacement: ESCAT (Early self-controlled anticoagulation trial) [in German]
    • Körtke H, Minami K, Breymann T, et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial) [in German]. Z Kardiol. 2001;90(suppl 6):118-124.
    • (2001) Z Kardiol , vol.90 , pp. 118-124
    • Körtke, H.1    Minami, K.2    Breymann, T.3
  • 69
    • 2442521480 scopus 로고    scopus 로고
    • SMART: Self-management of anticoagulation, a randomised trial [ISRCTN19313375]
    • McCahon D, Fitzmaurice DA, Murray ET, et al. SMART: self-management of anticoagulation, a randomised trial [ISRCTN19313375]. BMC Fam Pract. 2003;4:11.
    • (2003) BMC Fam Pract , vol.4 , pp. 11
    • McCahon, D.1    Fitzmaurice, D.A.2    Murray, E.T.3
  • 70
    • 79953151471 scopus 로고    scopus 로고
    • Does self-management of oral anticoagulation therapy improve quality of life and anxiety?
    • McCahon D, Murray ET, Murray K, Holder RL, Fitzmaurice DA. Does self-management of oral anticoagulation therapy improve quality of life and anxiety? Fam Pract. 2011;28(2):134-140.
    • (2011) Fam Pract , vol.28 , Issue.2 , pp. 134-140
    • McCahon, D.1    Murray, E.T.2    Murray, K.3    Holder, R.L.4    Fitzmaurice, D.A.5
  • 71
    • 1342301567 scopus 로고    scopus 로고
    • Training for patients in a randomised controlled trial of self management of warfarin treatment
    • Murray E, Fitzmaurice D, McCahon D, Fuller C, Sandhur H. Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ. 2004;328(7437):437-438.
    • (2004) BMJ , vol.328 , Issue.7437 , pp. 437-438
    • Murray, E.1    Fitzmaurice, D.2    McCahon, D.3    Fuller, C.4    Sandhur, H.5
  • 72
    • 84865229803 scopus 로고    scopus 로고
    • Self-management of oral anticoagulation in elderly patients - Effects on treatment-related quality of life
    • Siebenhofer A, Hemkens LG, Rakovac I, Spat S, Didjurgeit U; SPOG 601 Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thromb Res. 2012;130(3):e60-e66.
    • (2012) Thromb Res , vol.130 , Issue.3 , pp. e60-e66
    • Siebenhofer, A.1    Hemkens, L.G.2    Rakovac, I.3    Spat, S.4    Didjurgeit, U.5
  • 73
    • 57349121024 scopus 로고    scopus 로고
    • Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial
    • Siebenhofer A, Rakovac I, Kleespies C, Piso B, Didjurgeit U; SPOG 601 Study Group. Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thromb Haemost. 2008;100(6):1089-1098.
    • (2008) Thromb Haemost , vol.100 , Issue.6 , pp. 1089-1098
    • Siebenhofer, A.1    Rakovac, I.2    Kleespies, C.3    Piso, B.4    Didjurgeit, U.5
  • 74
    • 33745662843 scopus 로고    scopus 로고
    • Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy
    • Regier DA, Sunderji R, Lynd LD, Gin K, Marra CA. Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy. CMAJ. 2006;174(13):1847-1852.
    • (2006) CMAJ , vol.174 , Issue.13 , pp. 1847-1852
    • Regier, D.A.1    Sunderji, R.2    Lynd, L.D.3    Gin, K.4    Marra, C.A.5
  • 75
    • 33747381689 scopus 로고    scopus 로고
    • Patient self-management of anticoagulation therapy: A trial-based cost-effectiveness analysis
    • Jowett S, Bryan S, Murray E, et al. Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis. Br J Haematol. 2006; 134(6):632-639.
    • (2006) Br J Haematol , vol.134 , Issue.6 , pp. 632-639
    • Jowett, S.1    Bryan, S.2    Murray, E.3
  • 77
    • 84994417454 scopus 로고    scopus 로고
    • Predictors of anticoagulation quality in 15 834 patients performing patient self-management of oral anticoagulation with Vitamin K antagonists in real-life practice: A survey of the International Self-Monitoring Association of Orally Anticoagulated Patients
    • Schaefer C, Wuillemin WA, Kessels A, Jacobson A, Nagler M. Predictors of anticoagulation quality in 15 834 patients performing patient self-management of oral anticoagulation with vitamin K antagonists in real-life practice: a survey of the International Self-Monitoring Association of Orally Anticoagulated Patients. Br J Haematol. 2016;175(4):677-685.
    • (2016) Br J Haematol , vol.175 , Issue.4 , pp. 677-685
    • Schaefer, C.1    Wuillemin, W.A.2    Kessels, A.3    Jacobson, A.4    Nagler, M.5
  • 78
    • 84955513323 scopus 로고    scopus 로고
    • Center-related determinants of VKA anticoagulation quality: A prospective, multicenter evaluation
    • Tosetto A, Manotti C, Marongiu F; Italian Federation of Anticoagulation Clinics (FCSA) Clinical Quality Study Group. Center-related determinants of VKA anticoagulation quality: a prospective, multicenter evaluation. PLoS One. 2015;10(12):e0144314.
    • (2015) PLoS One , vol.10 , Issue.12
    • Tosetto, A.1    Manotti, C.2    Marongiu, F.3
  • 79
    • 0345258406 scopus 로고    scopus 로고
    • A comparison between six- and four-week intervals in surveillance of oral anticoagulant treatment
    • Pengo V, Barbero F, Biasiolo A, Pegoraro C, Cucchini U, Iliceto S. A comparison between six- and four-week intervals in surveillance of oral anticoagulant treatment. Am J Clin Pathol. 2003;120(6):944-947.
    • (2003) Am J Clin Pathol , vol.120 , Issue.6 , pp. 944-947
    • Pengo, V.1    Barbero, F.2    Biasiolo, A.3    Pegoraro, C.4    Cucchini, U.5    Iliceto, S.6
  • 80
    • 81055155535 scopus 로고    scopus 로고
    • Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: A randomized trial
    • Schulman S, Parpia S, Stewart C, Rudd-Scott L, Julian JA, Levine M. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial. Ann Intern Med. 2011;155(10):653-659.
    • (2011) Ann Intern Med , vol.155 , Issue.10 , pp. 653-659
    • Schulman, S.1    Parpia, S.2    Stewart, C.3    Rudd-Scott, L.4    Julian, J.A.5    Levine, M.6
  • 81
    • 84897443099 scopus 로고    scopus 로고
    • National assessment of warfarin anticoagulation therapy for stroke prevention in atrial fibrillation
    • Dlott JS, George RA, Huang X, et al. National assessment of warfarin anticoagulation therapy for stroke prevention in atrial fibrillation. Circulation. 2014; 129(13):1407-1414.
    • (2014) Circulation , vol.129 , Issue.13 , pp. 1407-1414
    • Dlott, J.S.1    George, R.A.2    Huang, X.3
  • 82
    • 0034518689 scopus 로고    scopus 로고
    • INR: Intervals of measurement can safely extend to 14 weeks
    • Lidstone V, Janes S, Stross P. INR: intervals of measurement can safely extend to 14 weeks. Clin Lab Haematol. 2000;22(5):291-293.
    • (2000) Clin Lab Haematol , vol.22 , Issue.5 , pp. 291-293
    • Lidstone, V.1    Janes, S.2    Stross, P.3
  • 83
    • 34248531250 scopus 로고    scopus 로고
    • The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation
    • Shalev V, Rogowski O, Shimron O, et al. The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation. Thromb Res. 2007;120(2):201-206.
    • (2007) Thromb Res , vol.120 , Issue.2 , pp. 201-206
    • Shalev, V.1    Rogowski, O.2    Shimron, O.3
  • 84
    • 33646449376 scopus 로고    scopus 로고
    • Meta-analysis: Low-molecular-weight heparin and bleeding in patients with severe renal insufficiency
    • Lim W, Dentali F, Eikelboom JW, Crowther MA. Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med. 2006;144(9):673-684.
    • (2006) Ann Intern Med , vol.144 , Issue.9 , pp. 673-684
    • Lim, W.1    Dentali, F.2    Eikelboom, J.W.3    Crowther, M.A.4
  • 85
    • 79958022690 scopus 로고    scopus 로고
    • Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: The INNOHEP® in renal insufficiency study (IRIS)
    • Leizorovicz A, Siguret V, Mottier D, et al; Innohep® in Renal Insufficiency Study Steering Committee. Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: the Innohep® in Renal Insufficiency Study (IRIS). Thromb Res. 2011;128(1):27-34.
    • (2011) Thromb Res , vol.128 , Issue.1 , pp. 27-34
    • Leizorovicz, A.1    Siguret, V.2    Mottier, D.3
  • 86
    • 17444425341 scopus 로고    scopus 로고
    • Dosage of enoxaparin among obese and renal impairment patients
    • Bazinet A, Almanric K, Brunet C, et al. Dosage of enoxaparin among obese and renal impairment patients. Thromb Res. 2005;116(1):41-50.
    • (2005) Thromb Res , vol.116 , Issue.1 , pp. 41-50
    • Bazinet, A.1    Almanric, K.2    Brunet, C.3
  • 87
    • 0038582288 scopus 로고    scopus 로고
    • Correlation of antifactor Xa concentrations with renal function in patients on enoxaparin
    • Chow SL, Zammit K, West K, Dannenhoffer M, Lopez-Candales A. Correlation of antifactor Xa concentrations with renal function in patients on enoxaparin. J Clin Pharmacol. 2003;43(6):586-590.
    • (2003) J Clin Pharmacol , vol.43 , Issue.6 , pp. 586-590
    • Chow, S.L.1    Zammit, K.2    West, K.3    Dannenhoffer, M.4    Lopez-Candales, A.5
  • 88
    • 5344247232 scopus 로고    scopus 로고
    • Retrospective evaluation of a pharmacokinetic program for adjusting enoxaparin in renal impairment
    • Kruse MW, Lee JJ. Retrospective evaluation of a pharmacokinetic program for adjusting enoxaparin in renal impairment. Am Heart J. 2004;148(4): 582-589.
    • (2004) Am Heart J , vol.148 , Issue.4 , pp. 582-589
    • Kruse, M.W.1    Lee, J.J.2
  • 89
    • 0036360980 scopus 로고    scopus 로고
    • Safety profile of tinzaparin administered once daily at a standard curative dose in two hundred very elderly patients
    • Pautas E, Gouin I, Bellot O, Andreux JP, Siguret V. Safety profile of tinzaparin administered once daily at a standard curative dose in two hundred very elderly patients. Drug Saf. 2002;25(10):725-733.
    • (2002) Drug Saf , vol.25 , Issue.10 , pp. 725-733
    • Pautas, E.1    Gouin, I.2    Bellot, O.3    Andreux, J.P.4    Siguret, V.5
  • 91
    • 0033710044 scopus 로고    scopus 로고
    • Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): Anti-Xa and anti-IIa activities over 10 days
    • Siguret V, Pautas E, Février M, et al. Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): anti-Xa and anti-IIa activities over 10 days. Thromb Haemost. 2000;84(5):800-804.
    • (2000) Thromb Haemost , vol.84 , Issue.5 , pp. 800-804
    • Siguret, V.1    Pautas, E.2    Février, M.3
  • 92
    • 80053024358 scopus 로고    scopus 로고
    • Effect of enoxaparin on peak and trough levels of antifactor Xa in patients with a creatinine clearance of less than 30 mL/min
    • Sule AA, Tay JC, Arul E. Effect of enoxaparin on peak and trough levels of antifactor Xa in patients with a creatinine clearance of less than 30 mL/min. Int J Angiol. 2009;18(4):184-186.
    • (2009) Int J Angiol , vol.18 , Issue.4 , pp. 184-186
    • Sule, A.A.1    Tay, J.C.2    Arul, E.3
  • 93
    • 85072746387 scopus 로고    scopus 로고
    • Evaluating current recommended dose of enoxaparin in renally impaired and morbidly obese patients by monitoring anti-factor Xa levels
    • abstract
    • Ballew A, Lee Y, Vega J, Duong HN. Evaluating current recommended dose of enoxaparin in renally impaired and morbidly obese patients by monitoring anti-factor Xa levels [abstract]. Pharmacotherapy. 2014;34(10):e273-e274.
    • (2014) Pharmacotherapy , vol.34 , Issue.10 , pp. e273-e274
    • Ballew, A.1    Lee, Y.2    Vega, J.3    Duong, H.N.4
  • 94
    • 34948905817 scopus 로고    scopus 로고
    • Enoxaparin dosage adjustment in patients with severe renal failure: Antifactor xa concentrations and safety
    • Lachish T, Rudensky B, Slotki I, Zevin S. Enoxaparin dosage adjustment in patients with severe renal failure: antifactor xa concentrations and safety. Pharmacotherapy. 2007;27(10):1347-1352.
    • (2007) Pharmacotherapy , vol.27 , Issue.10 , pp. 1347-1352
    • Lachish, T.1    Rudensky, B.2    Slotki, I.3    Zevin, S.4
  • 95
    • 84870165654 scopus 로고    scopus 로고
    • Are low-molecular-weight heparins appropriately dosed in patients with CKD stage 3 to 5?
    • Yildirim T, Kocak T, Buyukasik Y, et al. Are low-molecular-weight heparins appropriately dosed in patients with CKD stage 3 to 5? Blood Coagul Fibrinolysis. 2012;23(8):700-704.
    • (2012) Blood Coagul Fibrinolysis , vol.23 , Issue.8 , pp. 700-704
    • Yildirim, T.1    Kocak, T.2    Buyukasik, Y.3
  • 96
    • 1642326695 scopus 로고    scopus 로고
    • Anticoagulation in hospitalized patients with renal insufficiency: A comparison of bleeding rates with unfractionated heparin vs enoxaparin
    • Thorevska N, Amoateng-Adjepong Y, Sabahi R, et al. Anticoagulation in hospitalized patients with renal insufficiency: a comparison of bleeding rates with unfractionated heparin vs enoxaparin. Chest. 2004;125(3):856-863.
    • (2004) Chest , vol.125 , Issue.3 , pp. 856-863
    • Thorevska, N.1    Amoateng-Adjepong, Y.2    Sabahi, R.3
  • 97
    • 84878491863 scopus 로고    scopus 로고
    • Anti-Xa assays
    • Barras M. Anti-Xa assays. Aust Prescr. 2013;36(3):98-101.
    • (2013) Aust Prescr , vol.36 , Issue.3 , pp. 98-101
    • Barras, M.1
  • 98
    • 28044470299 scopus 로고    scopus 로고
    • How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? A laboratory perspective
    • Haematology
    • Favaloro EJ, Bonar R, Aboud M, et al; RCPA QAP in Haematology. How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? A laboratory perspective. Lab Hematol. 2005;11(3):157-162.
    • (2005) Lab Hematol , vol.11 , Issue.3 , pp. 157-162
    • Favaloro, E.J.1    Bonar, R.2    Aboud, M.3
  • 99
    • 21744432055 scopus 로고    scopus 로고
    • An international survey of current practice in the laboratory assessment of anticoagulant therapy with heparin
    • Royal College Pathologists of Australasia Quality Assurance Program in Haematology
    • Favaloro EJ, Bonar R, Sioufi J, et al; Royal College Pathologists of Australasia Quality Assurance Program in Haematology. An international survey of current practice in the laboratory assessment of anticoagulant therapy with heparin. Pathology. 2005;37(3):234-238.
    • (2005) Pathology , vol.37 , Issue.3 , pp. 234-238
    • Favaloro, E.J.1    Bonar, R.2    Sioufi, J.3
  • 100
    • 84857015053 scopus 로고    scopus 로고
    • Laboratory testing of anticoagulants: The present and the future
    • Favaloro EJ, Lippi G, Koutts J. Laboratory testing of anticoagulants: the present and the future. Pathology. 2011;43(7):682-692.
    • (2011) Pathology , vol.43 , Issue.7 , pp. 682-692
    • Favaloro, E.J.1    Lippi, G.2    Koutts, J.3
  • 101
    • 84939788404 scopus 로고    scopus 로고
    • Measuring anti-factor xa activity to monitor low-molecular-weight heparin in obesity: A critical review
    • Egan G, Ensom MH. Measuring anti-factor xa activity to monitor low-molecular-weight heparin in obesity: a critical review. Can J Hosp Pharm. 2015; 68(1):33-47.
    • (2015) Can J Hosp Pharm , vol.68 , Issue.1 , pp. 33-47
    • Egan, G.1    Ensom, M.H.2
  • 102
    • 80052443962 scopus 로고    scopus 로고
    • Evaluation of therapeutic anticoagulation with enoxaparin and associated anti-Xa monitoring in patients with morbid obesity: A case series
    • Deal EN, Hollands JM, Riney JN, Skrupky LP, Smith JR, Reichley RM. Evaluation of therapeutic anticoagulation with enoxaparin and associated anti-Xa monitoring in patients with morbid obesity: a case series. J Thromb Thrombolysis. 2011;32(2):188-194.
    • (2011) J Thromb Thrombolysis , vol.32 , Issue.2 , pp. 188-194
    • Deal, E.N.1    Hollands, J.M.2    Riney, J.N.3    Skrupky, L.P.4    Smith, J.R.5    Reichley, R.M.6
  • 104
    • 0036257203 scopus 로고    scopus 로고
    • Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: A pharmacodynamic study
    • Hainer JW, Barrett JS, Assaid CA, et al. Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: a pharmacodynamic study. Thromb Haemost. 2002;87(5):817-823.
    • (2002) Thromb Haemost , vol.87 , Issue.5 , pp. 817-823
    • Hainer, J.W.1    Barrett, J.S.2    Assaid, C.A.3
  • 105
    • 0037528877 scopus 로고    scopus 로고
    • Weight-based administration of dalteparin in obese patients
    • Smith J, Canton EM. Weight-based administration of dalteparin in obese patients. Am J Health Syst Pharm. 2003;60(7):683-687.
    • (2003) Am J Health Syst Pharm , vol.60 , Issue.7 , pp. 683-687
    • Smith, J.1    Canton, E.M.2
  • 106
    • 84905747093 scopus 로고    scopus 로고
    • Rates, management, and outcome of rivaroxaban bleeding in daily care: Results from the Dresden NOAC registry
    • Beyer-Westendorf J, Förster K, Pannach S, et al. Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry. Blood. 2014;124(6):955-962.
    • (2014) Blood , vol.124 , Issue.6 , pp. 955-962
    • Beyer-Westendorf, J.1    Förster, K.2    Pannach, S.3
  • 107
    • 84940438619 scopus 로고    scopus 로고
    • Intracranial haemorrhage in patients treated with direct oral anticoagulants
    • Beynon C, Sakowitz OW, Störzinger D, et al. Intracranial haemorrhage in patients treated with direct oral anticoagulants. Thromb Res. 2015;136(3): 560-565.
    • (2015) Thromb Res , vol.136 , Issue.3 , pp. 560-565
    • Beynon, C.1    Sakowitz, O.W.2    Störzinger, D.3
  • 108
    • 84940900808 scopus 로고    scopus 로고
    • Clinical impact and course of major bleeding with rivaroxaban and Vitamin K antagonists
    • Eerenberg ES, Middeldorp S, Levi M, Lensing AW, Büller HR. Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists. J Thromb Haemost. 2015;13(9):1590-1596.
    • (2015) J Thromb Haemost , vol.13 , Issue.9 , pp. 1590-1596
    • Eerenberg, E.S.1    Middeldorp, S.2    Levi, M.3    Lensing, A.W.4    Büller, H.R.5
  • 109
    • 84946135517 scopus 로고    scopus 로고
    • A review of and recommendations for the management of patients with life-threatening dabigatran-associated hemorrhage: A single-center university hospital experience
    • Kumar R, Smith RE, Henry BL. A review of and recommendations for the management of patients with life-threatening dabigatran-associated hemorrhage: a single-center university hospital experience. J Intensive Care Med. 2015;30(8):462-472.
    • (2015) J Intensive Care Med , vol.30 , Issue.8 , pp. 462-472
    • Kumar, R.1    Smith, R.E.2    Henry, B.L.3
  • 110
    • 84966525948 scopus 로고    scopus 로고
    • The real-world treatment of hemorrhages associated with dabigatran and rivaroxaban: A multicenter evaluation
    • Pahs L, Beavers C, Schuler P. The real-world treatment of hemorrhages associated with dabigatran and rivaroxaban: a multicenter evaluation. Crit Pathw Cardiol. 2015;14(2):53-61.
    • (2015) Crit Pathw Cardiol , vol.14 , Issue.2 , pp. 53-61
    • Pahs, L.1    Beavers, C.2    Schuler, P.3
  • 111
    • 84904129516 scopus 로고    scopus 로고
    • Management of major bleeding events in patients treated with rivaroxaban vs. Warfarin: Results from the ROCKET AF trial
    • Piccini JP, Garg J, Patel MR, et al; ROCKET AF Investigators. Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial. Eur Heart J. 2014;35(28):1873-1880.
    • (2014) Eur Heart J , vol.35 , Issue.28 , pp. 1873-1880
    • Piccini, J.P.1    Garg, J.2    Patel, M.R.3
  • 112
    • 84964788312 scopus 로고    scopus 로고
    • Early clinical and radiological course, management, and outcome of intracerebral hemorrhage related to new oral anticoagulants
    • Purrucker JC, Haas K, Rizos T, et al. Early clinical and radiological course, management, and outcome of intracerebral hemorrhage related to new oral anticoagulants. JAMA Neurol. 2016;73(2):169-177.
    • (2016) JAMA Neurol , vol.73 , Issue.2 , pp. 169-177
    • Purrucker, J.C.1    Haas, K.2    Rizos, T.3
  • 113
    • 84959178601 scopus 로고    scopus 로고
    • New target-specific oral anticoagulants and intracranial bleeding: Management and outcome in a single-center case series
    • Senger S, Keiner D, Hendrix P, Oertel J. New target-specific oral anticoagulants and intracranial bleeding: management and outcome in a single-center case series. World Neurosurg. 2016;88:132-139.
    • (2016) World Neurosurg , vol.88 , pp. 132-139
    • Senger, S.1    Keiner, D.2    Hendrix, P.3    Oertel, J.4
  • 114
    • 84925883985 scopus 로고    scopus 로고
    • Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
    • published correction Am Heart J. 2015;169(4): 594
    • Granger CB, Lopes RD, Hanna M, et al. Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial [published correction appears in Am Heart J. 2015;169(4): 594]. Am Heart J. 2015;169(1):25-30.
    • (2015) Am Heart J , vol.169 , Issue.1 , pp. 25-30
    • Granger, C.B.1    Lopes, R.D.2    Hanna, M.3
  • 115
    • 84884492931 scopus 로고    scopus 로고
    • End of study transition from study drug to open-label Vitamin K antagonist therapy: The ROCKET AF experience
    • Mahaffey KW, Hellkamp AS, Patel MR, et al. End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience. Circ Cardiovasc Qual Outcomes. 2013;6(4):470-478.
    • (2013) Circ Cardiovasc Qual Outcomes , vol.6 , Issue.4 , pp. 470-478
    • Mahaffey, K.W.1    Hellkamp, A.S.2    Patel, M.R.3
  • 116
    • 84905683957 scopus 로고    scopus 로고
    • Transition of patients from blinded study drug to open-label anticoagulation: The ENGAGE AF-TIMI 48 trial
    • Ruff CT, Giugliano RP, Braunwald E, et al. Transition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF-TIMI 48 trial. J Am Coll Cardiol. 2014;64(6):576-584.
    • (2014) J Am Coll Cardiol , vol.64 , Issue.6 , pp. 576-584
    • Ruff, C.T.1    Giugliano, R.P.2    Braunwald, E.3
  • 117
    • 84990842207 scopus 로고    scopus 로고
    • Comparing the effectiveness of pharmacist-managed warfarin anticoagulation with other models: A systematic review and meta-analysis
    • Zhou S, Sheng XY, Xiang Q, Wang ZN, Zhou Y, Cui YM. Comparing the effectiveness of pharmacist-managed warfarin anticoagulation with other models: a systematic review and meta-analysis. J Clin Pharm Ther. 2016;41(6):602-611.
    • (2016) J Clin Pharm Ther , vol.41 , Issue.6 , pp. 602-611
    • Zhou, S.1    Sheng, X.Y.2    Xiang, Q.3    Wang, Z.N.4    Zhou, Y.5    Cui, Y.M.6
  • 118
    • 65749110116 scopus 로고    scopus 로고
    • Clinical outcomes and pharmacists' acceptance of a community hospital's anticoagulation management service utilizing decentralized clinical staff pharmacists
    • Airee A, Guirguis AB, Mohammad RA. Clinical outcomes and pharmacists' acceptance of a community hospital's anticoagulation management service utilizing decentralized clinical staff pharmacists. Ann Pharmacother. 2009;43(4):621-628.
    • (2009) Ann Pharmacother , vol.43 , Issue.4 , pp. 621-628
    • Airee, A.1    Guirguis, A.B.2    Mohammad, R.A.3
  • 119
    • 84874594078 scopus 로고    scopus 로고
    • Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
    • Arbring K, Uppugunduri S, Lindahl TL. Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics. BMC Health Serv Res. 2013;13(1):85.
    • (2013) BMC Health Serv Res , vol.13 , Issue.1 , pp. 85
    • Arbring, K.1    Uppugunduri, S.2    Lindahl, T.L.3
  • 121
    • 0035234513 scopus 로고    scopus 로고
    • Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic
    • Chamberlain MA, Sageser NA, Ruiz D. Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic. J Am Board Fam Pract. 2001;14(1):16-21.
    • (2001) J Am Board Fam Pract , vol.14 , Issue.1 , pp. 16-21
    • Chamberlain, M.A.1    Sageser, N.A.2    Ruiz, D.3
  • 122
    • 0032563666 scopus 로고    scopus 로고
    • Comparison of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes, and health care costs
    • Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998;158(15):1641-1647.
    • (1998) Arch Intern Med , vol.158 , Issue.15 , pp. 1641-1647
    • Chiquette, E.1    Amato, M.G.2    Bussey, H.I.3
  • 123
    • 79956150218 scopus 로고    scopus 로고
    • Impact of a pharmacotherapeutic programme on control and safety of long-term anticoagulation treatment: A controlled follow-up study in Spain
    • Duran-Parrondo C, Vazquez-Lago JM, Campos-Lopez AM, Figueiras A. Impact of a pharmacotherapeutic programme on control and safety of long-term anticoagulation treatment: a controlled follow-up study in Spain. Drug Saf. 2011;34(6):489-500.
    • (2011) Drug Saf , vol.34 , Issue.6 , pp. 489-500
    • Duran-Parrondo, C.1    Vazquez-Lago, J.M.2    Campos-Lopez, A.M.3    Figueiras, A.4
  • 124
    • 1542435012 scopus 로고    scopus 로고
    • Evaluation of 4 years of clinical pharmacist anticoagulation case management in a rural, private physician office
    • Ernst ME, Brandt KB. Evaluation of 4 years of clinical pharmacist anticoagulation case management in a rural, private physician office. J Am Pharm Assoc. 2003;43(5):630-636.
    • (2003) J Am Pharm Assoc , vol.43 , Issue.5 , pp. 630-636
    • Ernst, M.E.1    Brandt, K.B.2
  • 125
    • 82955163164 scopus 로고    scopus 로고
    • A retrospective assessment comparing pharmacist-managed anticoagulation clinic with physician management using international normalized ratio stability
    • Garton L, Crosby JF. A retrospective assessment comparing pharmacist-managed anticoagulation clinic with physician management using international normalized ratio stability. J Thromb Thrombolysis. 2011;32(4):426-430.
    • (2011) J Thromb Thrombolysis , vol.32 , Issue.4 , pp. 426-430
    • Garton, L.1    Crosby, J.F.2
  • 126
    • 0036835792 scopus 로고    scopus 로고
    • Benefits of a mobile, point-of-care anticoagulation therapy management program
    • Gill JM, Landis MK. Benefits of a mobile, point-of-care anticoagulation therapy management program. Jt Comm J Qual Improv. 2002;28(11): 625-630.
    • (2002) Jt Comm J Qual Improv , vol.28 , Issue.11 , pp. 625-630
    • Gill, J.M.1    Landis, M.K.2
  • 127
    • 84927674789 scopus 로고    scopus 로고
    • Anticoagulation management by community pharmacists in New Zealand: An evaluation of a collaborative model in primary care
    • Harrison J, Shaw JP, Harrison JE. Anticoagulation management by community pharmacists in New Zealand: an evaluation of a collaborative model in primary care. Int J Pharm Pract. 2015;23(3):173-181.
    • (2015) Int J Pharm Pract , vol.23 , Issue.3 , pp. 173-181
    • Harrison, J.1    Shaw, J.P.2    Harrison, J.E.3
  • 128
    • 0034025258 scopus 로고    scopus 로고
    • Comparative effectiveness of general practitioner versus pharmacist dosing of patients requiring anticoagulation in the community
    • Holden J, Holden K. Comparative effectiveness of general practitioner versus pharmacist dosing of patients requiring anticoagulation in the community. J Clin Pharm Ther. 2000;25(1):49-54.
    • (2000) J Clin Pharm Ther , vol.25 , Issue.1 , pp. 49-54
    • Holden, J.1    Holden, K.2
  • 129
    • 0037087020 scopus 로고    scopus 로고
    • Prospective evaluation of the quality of oral anticoagulation management in an outpatient clinic and in general practices
    • Holm T, Deutch S, Lassen JF, Jastrup B, Husted SE, Heickendorff L. Prospective evaluation of the quality of oral anticoagulation management in an outpatient clinic and in general practices. Thromb Res. 2002;105(2):103-108.
    • (2002) Thromb Res , vol.105 , Issue.2 , pp. 103-108
    • Holm, T.1    Deutch, S.2    Lassen, J.F.3    Jastrup, B.4    Husted, S.E.5    Heickendorff, L.6
  • 130
    • 84891457517 scopus 로고    scopus 로고
    • Adherence and outcomes of patients treated with dabigatran: Pharmacist-managed anticoagulation clinic versus usual care
    • Lee PY, Han SY, Miyahara RK. Adherence and outcomes of patients treated with dabigatran: pharmacist-managed anticoagulation clinic versus usual care. Am J Health Syst Pharm. 2013;70(13):1154-1161.
    • (2013) Am J Health Syst Pharm , vol.70 , Issue.13 , pp. 1154-1161
    • Lee, P.Y.1    Han, S.Y.2    Miyahara, R.K.3
  • 131
    • 0030015483 scopus 로고    scopus 로고
    • Effect of a pharmacist-managed anticoagulation clinic on warfarin-related hospital readmissions
    • Lee YP, Schommer JC. Effect of a pharmacist-managed anticoagulation clinic on warfarin-related hospital readmissions. Am J Health Syst Pharm. 1996; 53(13):1580-1583.
    • (1996) Am J Health Syst Pharm , vol.53 , Issue.13 , pp. 1580-1583
    • Lee, Y.P.1    Schommer, J.C.2
  • 132
    • 79960504862 scopus 로고    scopus 로고
    • A collaborative care model of anticoagulation therapy in patients with stroke
    • Lee TY, Po HL, Jin YJ, Tsun WJ, Wang SC. A collaborative care model of anticoagulation therapy in patients with stroke. Neurol Asia. 2011;16(2): 111-118.
    • (2011) Neurol Asia , vol.16 , Issue.2 , pp. 111-118
    • Lee, T.Y.1    Po, H.L.2    Jin, Y.J.3    Tsun, W.J.4    Wang, S.C.5
  • 133
    • 84865438341 scopus 로고    scopus 로고
    • Monitoring of international normalized ratios: Comparison of community nurses with family physicians
    • Levine MA, Shao W, Klein D. Monitoring of international normalized ratios: comparison of community nurses with family physicians. Can Fam Physician. 2012;58(8):e465-e471.
    • (2012) Can Fam Physician , vol.58 , Issue.8 , pp. e465-e471
    • Levine, M.A.1    Shao, W.2    Klein, D.3
  • 134
    • 18044368631 scopus 로고    scopus 로고
    • Reduction in warfarin adverse events requiring patient hospitalization after implementation of a pharmacist-managed anticoagulation service
    • Locke C, Ravnan SL, Patel R, Uchizono JA. Reduction in warfarin adverse events requiring patient hospitalization after implementation of a pharmacist-managed anticoagulation service. Pharmacotherapy. 2005;25(5):685-689.
    • (2005) Pharmacotherapy , vol.25 , Issue.5 , pp. 685-689
    • Locke, C.1    Ravnan, S.L.2    Patel, R.3    Uchizono, J.A.4
  • 135
    • 38049086610 scopus 로고    scopus 로고
    • Quality of anticoagulation monitoring in nonvalvular atrial fibrillation patients: Comparison of anticoagulation clinic versus usual care
    • Nichol MB, Knight TK, Dow T, et al. Quality of anticoagulation monitoring in nonvalvular atrial fibrillation patients: comparison of anticoagulation clinic versus usual care. Ann Pharmacother. 2008;42(1):62-70.
    • (2008) Ann Pharmacother , vol.42 , Issue.1 , pp. 62-70
    • Nichol, M.B.1    Knight, T.K.2    Dow, T.3
  • 137
    • 33846798432 scopus 로고    scopus 로고
    • The impact of pharmacist-managed oral anticoagulation therapy in older veterans
    • Poon IO, Lal L, Brown EN, Braun UK. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. J Clin Pharm Ther. 2007;32(1): 21-29.
    • (2007) J Clin Pharm Ther , vol.32 , Issue.1 , pp. 21-29
    • Poon, I.O.1    Lal, L.2    Brown, E.N.3    Braun, U.K.4
  • 138
    • 84860796607 scopus 로고    scopus 로고
    • Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand
    • Saokaew S, Sapoo U, Nathisuwan S, Chaiyakunapruk N, Permsuwan U. Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand. Int J Clin Pharm. 2012;34(1):105-112.
    • (2012) Int J Clin Pharm , vol.34 , Issue.1 , pp. 105-112
    • Saokaew, S.1    Sapoo, U.2    Nathisuwan, S.3    Chaiyakunapruk, N.4    Permsuwan, U.5
  • 139
    • 84927948517 scopus 로고    scopus 로고
    • Site-level variation in and practices associated with dabigatran adherence
    • Shore S, Ho PM, Lambert-Kerzner A, et al. Site-level variation in and practices associated with dabigatran adherence. JAMA. 2015;313(14):1443-1450.
    • (2015) JAMA , vol.313 , Issue.14 , pp. 1443-1450
    • Shore, S.1    Ho, P.M.2    Lambert-Kerzner, A.3
  • 140
    • 79952636526 scopus 로고    scopus 로고
    • Clinical outcomes of a collaborative, home-based postdischarge warfarin management service
    • Stafford L, Peterson GM, Bereznicki LR, et al. Clinical outcomes of a collaborative, home-based postdischarge warfarin management service. Ann Pharmacother. 2011;45(3):325-334.
    • (2011) Ann Pharmacother , vol.45 , Issue.3 , pp. 325-334
    • Stafford, L.1    Peterson, G.M.2    Bereznicki, L.R.3
  • 141
    • 84886088419 scopus 로고    scopus 로고
    • Comparing effectiveness of two anticoagulation management models in a Malaysian tertiary hospital
    • Thanimalai S, Shafie AA, Hassali MA, Sinnadurai J. Comparing effectiveness of two anticoagulation management models in a Malaysian tertiary hospital. Int J Clin Pharm. 2013;35(5):736-743.
    • (2013) Int J Clin Pharm , vol.35 , Issue.5 , pp. 736-743
    • Thanimalai, S.1    Shafie, A.A.2    Hassali, M.A.3    Sinnadurai, J.4
  • 142
    • 34248547921 scopus 로고    scopus 로고
    • Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics
    • Wallvik J, Själander A, Johansson L, Bjuhr O, Jansson JH. Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics. Scand J Prim Health Care. 2007;25(2):123-128.
    • (2007) Scand J Prim Health Care , vol.25 , Issue.2 , pp. 123-128
    • Wallvik, J.1    Själander, A.2    Johansson, L.3    Bjuhr, O.4    Jansson, J.H.5
  • 143
    • 0028808320 scopus 로고
    • Outcome analysis of a pharmacist-managed anticoagulation service
    • Wilt VM, Gums JG, Ahmed OI, Moore LM. Outcome analysis of a pharmacist-managed anticoagulation service. Pharmacotherapy. 1995;15(6):732-739.
    • (1995) Pharmacotherapy , vol.15 , Issue.6 , pp. 732-739
    • Wilt, V.M.1    Gums, J.G.2    Ahmed, O.I.3    Moore, L.M.4
  • 144
    • 0345602925 scopus 로고    scopus 로고
    • A retrospective evaluation of the management of excessive anticoagulation in an established clinical pharmacy anticoagulation service compared to traditional care
    • Witt DM, Humphries TL. A retrospective evaluation of the management of excessive anticoagulation in an established clinical pharmacy anticoagulation service compared to traditional care. J Thromb Thrombolysis. 2003;15(2):113-118.
    • (2003) J Thromb Thrombolysis , vol.15 , Issue.2 , pp. 113-118
    • Witt, D.M.1    Humphries, T.L.2
  • 145
    • 19844366428 scopus 로고    scopus 로고
    • Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy
    • Witt DM, Sadler MA, Shanahan RL, Mazzoli G, Tillman DJ. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest. 2005;127(5):1515-1522.
    • (2005) Chest , vol.127 , Issue.5 , pp. 1515-1522
    • Witt, D.M.1    Sadler, M.A.2    Shanahan, R.L.3    Mazzoli, G.4    Tillman, D.J.5
  • 146
    • 80051658000 scopus 로고    scopus 로고
    • Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic
    • Young S, Bishop L, Twells L, Dillon C, Hawboldt J, O'Shea P. Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic. BMC Fam Pract. 2011;12(1):88.
    • (2011) BMC Fam Pract , vol.12 , Issue.1 , pp. 88
    • Young, S.1    Bishop, L.2    Twells, L.3    Dillon, C.4    Hawboldt, J.5    O'Shea, P.6
  • 147
    • 45649083857 scopus 로고    scopus 로고
    • Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial
    • Lalonde L, Martineau J, Blais N, et al. Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial. Am Heart J. 2008;156(1):148-154.
    • (2008) Am Heart J , vol.156 , Issue.1 , pp. 148-154
    • Lalonde, L.1    Martineau, J.2    Blais, N.3
  • 148
    • 84979683956 scopus 로고    scopus 로고
    • Modelling the cost-effectiveness of pharmacist-managed anticoagulation service for older adults with atrial fibrillation in Singapore
    • Chua WB, Cheen HH, Kong MC, Chen LL, Wee HL. Modelling the cost-effectiveness of pharmacist-managed anticoagulation service for older adults with atrial fibrillation in Singapore. Int J Clin Pharm. 2016;38(5):1230-1240.
    • (2016) Int J Clin Pharm , vol.38 , Issue.5 , pp. 1230-1240
    • Chua, W.B.1    Cheen, H.H.2    Kong, M.C.3    Chen, L.L.4    Wee, H.L.5
  • 149
    • 0033984098 scopus 로고    scopus 로고
    • The cost-effectiveness of different management strategies for patients on chronic warfarin therapy
    • Lafata JE, Martin SA, Kaatz S, Ward RE. The cost-effectiveness of different management strategies for patients on chronic warfarin therapy. J Gen Intern Med. 2000;15(1):31-37.
    • (2000) J Gen Intern Med , vol.15 , Issue.1 , pp. 31-37
    • Lafata, J.E.1    Martin, S.A.2    Kaatz, S.3    Ward, R.E.4
  • 150
    • 80054865805 scopus 로고    scopus 로고
    • Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care
    • Aziz F, Corder M, Wolffe J, Comerota AJ. Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care. J Vasc Surg. 2011;54(5):1404-1407.
    • (2011) J Vasc Surg , vol.54 , Issue.5 , pp. 1404-1407
    • Aziz, F.1    Corder, M.2    Wolffe, J.3    Comerota, A.J.4
  • 151
    • 85040565617 scopus 로고    scopus 로고
    • Cost-effectiveness of the pharmacist-assisted warfarin monitoring program at a medical center in Taiwan
    • Chang JY, Wang CC, Kang HC, Shen LJ, Huang CF. Cost-effectiveness of the pharmacist-assisted warfarin monitoring program at a medical center in Taiwan. Int J Qual Health Care. 2017;29(6):817-825.
    • (2017) Int J Qual Health Care , vol.29 , Issue.6 , pp. 817-825
    • Chang, J.Y.1    Wang, C.C.2    Kang, H.C.3    Shen, L.J.4    Huang, C.F.5
  • 152
    • 84874970289 scopus 로고    scopus 로고
    • Supplemental patient education for patients taking oral anticoagulants: Systematic review and meta-analysis
    • Wong PY, Schulman S, Woodworth S, Holbrook A. Supplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysis. J Thromb Haemost. 2013;11(3):491-502.
    • (2013) J Thromb Haemost , vol.11 , Issue.3 , pp. 491-502
    • Wong, P.Y.1    Schulman, S.2    Woodworth, S.3    Holbrook, A.4
  • 153
    • 0015384833 scopus 로고
    • Evaluation of the use of programmed instruction for patients maintained on Warfarin therapy
    • Clark CM, Bayley EW. Evaluation of the use of programmed instruction for patients maintained on Warfarin therapy. Am J Public Health. 1972;62(8): 1135-1139.
    • (1972) Am J Public Health , vol.62 , Issue.8 , pp. 1135-1139
    • Clark, C.M.1    Bayley, E.W.2
  • 154
    • 84883622790 scopus 로고    scopus 로고
    • Educational intervention improves anticoagulation control in atrial fibrillation patients: The TREAT randomised trial
    • Clarkesmith DE, Pattison HM, Lip GY, Lane DA. Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial. PLoS One. 2013;8(9):e74037.
    • (2013) PLoS One , vol.8 , Issue.9
    • Clarkesmith, D.E.1    Pattison, H.M.2    Lip, G.Y.3    Lane, D.A.4
  • 155
    • 0037340166 scopus 로고    scopus 로고
    • Compliance and stability of INR of two oral anticoagulants with different half-lives: A randomised trial
    • Laporte S, Quenet S, Buchmüller-Cordier A, et al. Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial. Thromb Haemost. 2003;89(3):458-467.
    • (2003) Thromb Haemost , vol.89 , Issue.3 , pp. 458-467
    • Laporte, S.1    Quenet, S.2    Buchmüller-Cordier, A.3
  • 156
    • 84904057178 scopus 로고    scopus 로고
    • The effects of an informational video on patient knowledge, satisfaction and compliance with venous thromboembolism prophylaxis: A pilot study
    • Marini BL, Funk K, Kraft MD, et al. The effects of an informational video on patient knowledge, satisfaction and compliance with venous thromboembolism prophylaxis: a pilot study. Patient Educ Couns. 2014;96(2):264-267.
    • (2014) Patient Educ Couns , vol.96 , Issue.2 , pp. 264-267
    • Marini, B.L.1    Funk, K.2    Kraft, M.D.3
  • 157
    • 35748979131 scopus 로고    scopus 로고
    • Patient education about anticoagulant medication: Is narrative evidence or statistical evidence more effective?
    • Mazor KM, Baril J, Dugan E, Spencer F, Burgwinkle P, Gurwitz JH. Patient education about anticoagulant medication: is narrative evidence or statistical evidence more effective? Patient Educ Couns. 2007;69(1-3):145-157.
    • (2007) Patient Educ Couns , vol.69 , Issue.1-3 , pp. 145-157
    • Mazor, K.M.1    Baril, J.2    Dugan, E.3    Spencer, F.4    Burgwinkle, P.5    Gurwitz, J.H.6
  • 158
    • 50049104169 scopus 로고    scopus 로고
    • Educ'avk: Reduction of oral anticoagulant-related adverse events after patient education: A prospective multicenter open randomized study
    • Pernod G, Labarère J, Yver J, et al. EDUC'AVK: reduction of oral anticoagulant-related adverse events after patient education: a prospective multicenter open randomized study. J Gen Intern Med. 2008;23(9):1441-1446.
    • (2008) J Gen Intern Med , vol.23 , Issue.9 , pp. 1441-1446
    • Pernod, G.1    Labarère, J.2    Yver, J.3
  • 159
    • 84907509143 scopus 로고    scopus 로고
    • Educating orally anticoagulated patients in drug safety: A cluster-randomized study in general practice
    • Vormfelde SV, Abu Abed M, Hua TD, Schneider S, Friede T, Chenot JF. Educating orally anticoagulated patients in drug safety: a cluster-randomized study in general practice. Dtsch Arztebl Int. 2014;111(37):607-614.
    • (2014) Dtsch Arztebl Int , vol.111 , Issue.37 , pp. 607-614
    • Vormfelde, S.V.1    Abu Abed, M.2    Hua, T.D.3    Schneider, S.4    Friede, T.5    Chenot, J.F.6
  • 160
    • 84859418551 scopus 로고    scopus 로고
    • A new taxonomy for describing and defining adherence to medications
    • Vrijens B, De Geest S, Hughes DA, et al; ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691-705.
    • (2012) Br J Clin Pharmacol , vol.73 , Issue.5 , pp. 691-705
    • Vrijens, B.1    De Geest, S.2    Hughes, D.A.3
  • 161
    • 1642397582 scopus 로고    scopus 로고
    • Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research
    • DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3): 200-209.
    • (2004) Med Care , vol.42 , Issue.3 , pp. 200-209
    • DiMatteo, M.R.1
  • 162
    • 84992503728 scopus 로고    scopus 로고
    • A randomized trial of lottery-based incentives and reminders to improve warfarin adherence: The warfarin Incentives (WiN2) trial
    • Kimmel SE, Troxel AB, French B, et al. A randomized trial of lottery-based incentives and reminders to improve warfarin adherence: the Warfarin Incentives (WIN2) Trial. Pharmacoepidemiol Drug Saf. 2016;25(11):1219-1227.
    • (2016) Pharmacoepidemiol Drug Saf , vol.25 , Issue.11 , pp. 1219-1227
    • Kimmel, S.E.1    Troxel, A.B.2    French, B.3
  • 163
    • 84864646656 scopus 로고    scopus 로고
    • Randomized trial of lottery-based incentives to improve warfarin adherence
    • Kimmel SE, Troxel AB, Loewenstein G, et al. Randomized trial of lottery-based incentives to improve warfarin adherence. Am Heart J. 2012;164(2): 268-274.
    • (2012) Am Heart J , vol.164 , Issue.2 , pp. 268-274
    • Kimmel, S.E.1    Troxel, A.B.2    Loewenstein, G.3
  • 165
    • 85034813588 scopus 로고    scopus 로고
    • CDC grand rounds: Improving medication adherence for chronic disease management - Innovations and opportunities
    • Neiman AB, Ruppar T, Ho M, et al. CDC grand rounds: improving medication adherence for chronic disease management - innovations and opportunities. MMWR Morb Mortal Wkly Rep. 2017;66(45):1248-1251.
    • (2017) MMWR Morb Mortal Wkly Rep , vol.66 , Issue.45 , pp. 1248-1251
    • Neiman, A.B.1    Ruppar, T.2    Ho, M.3
  • 166
    • 84878229656 scopus 로고    scopus 로고
    • GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength
    • Andrews JC, Schünemann HJ, Oxman AD, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol. 2013;66(7):726-735.
    • (2013) J Clin Epidemiol , vol.66 , Issue.7 , pp. 726-735
    • Andrews, J.C.1    Schünemann, H.J.2    Oxman, A.D.3
  • 167
    • 84866698766 scopus 로고    scopus 로고
    • Periprocedural heparin bridging in patients receiving Vitamin K antagonists: Systematic review and meta-analysis of bleeding and thromboembolic rates
    • Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation. 2012;126(13):1630-1639.
    • (2012) Circulation , vol.126 , Issue.13 , pp. 1630-1639
    • Siegal, D.1    Yudin, J.2    Kaatz, S.3    Douketis, J.D.4    Lim, W.5    Spyropoulos, A.C.6
  • 168
    • 84937468318 scopus 로고    scopus 로고
    • Bleeding, recurrent venous thromboembolism, and mortality risks during warfarin interruption for invasive procedures
    • Clark NP, Witt DM, Davies LE, et al. Bleeding, recurrent venous thromboembolism, and mortality risks during warfarin interruption for invasive procedures. JAMA Intern Med. 2015;175(7):1163-1168.
    • (2015) JAMA Intern Med , vol.175 , Issue.7 , pp. 1163-1168
    • Clark, N.P.1    Witt, D.M.2    Davies, L.E.3
  • 169
    • 84878357643 scopus 로고    scopus 로고
    • Pacemaker or defibrillator surgery without interruption of anticoagulation
    • Birnie DH, Healey JS, Wells GA, et al; BRUISE CONTROL Investigators. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med. 2013;368(22):2084-2093.
    • (2013) N Engl J Med , vol.368 , Issue.22 , pp. 2084-2093
    • Birnie, D.H.1    Healey, J.S.2    Wells, G.A.3
  • 170
    • 84901718244 scopus 로고    scopus 로고
    • Peri-interventional management of novel oral anticoagulants in daily care: Results from the prospective Dresden NOAC registry
    • Beyer-Westendorf J, Gelbricht V, Förster K, et al. Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry. Eur Heart J. 2014;35(28):1888-1896.
    • (2014) Eur Heart J , vol.35 , Issue.28 , pp. 1888-1896
    • Beyer-Westendorf, J.1    Gelbricht, V.2    Förster, K.3
  • 171
    • 84955195962 scopus 로고    scopus 로고
    • Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure
    • Douketis JD, Wang G, Chan N, et al. Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure. J Thromb Haemost. 2016;14(1):89-97.
    • (2016) J Thromb Haemost , vol.14 , Issue.1 , pp. 89-97
    • Douketis, J.D.1    Wang, G.2    Chan, N.3
  • 172
    • 84941879698 scopus 로고    scopus 로고
    • Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations
    • Godier A, Martin AC, Leblanc I, et al. Peri-procedural management of dabigatran and rivaroxaban: duration of anticoagulant discontinuation and drug concentrations. Thromb Res. 2015;136(4):763-768.
    • (2015) Thromb Res , vol.136 , Issue.4 , pp. 763-768
    • Godier, A.1    Martin, A.C.2    Leblanc, I.3
  • 173
    • 84875753938 scopus 로고    scopus 로고
    • Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation
    • Kim JS, She F, Jongnarangsin K, et al. Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm. 2013;10(4):483-489.
    • (2013) Heart Rhythm , vol.10 , Issue.4 , pp. 483-489
    • Kim, J.S.1    She, F.2    Jongnarangsin, K.3
  • 174
    • 84937708837 scopus 로고    scopus 로고
    • Perioperative management of dabigatran: A prospective cohort study
    • Schulman S, Carrier M, Lee AY, et al; Periop Dabigatran Study Group. Perioperative management of dabigatran: a prospective cohort study. Circulation. 2015;132(3):167-173.
    • (2015) Circulation , vol.132 , Issue.3 , pp. 167-173
    • Schulman, S.1    Carrier, M.2    Lee, A.Y.3
  • 175
    • 33644592680 scopus 로고    scopus 로고
    • Treatment of excessive anticoagulation with phytonadione (Vitamin K): A meta-analysis
    • Dezee KJ, Shimeall WT, Douglas KM, Shumway NM, O'malley PG. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis. Arch Intern Med. 2006;166(4):391-397.
    • (2006) Arch Intern Med , vol.166 , Issue.4 , pp. 391-397
    • Dezee, K.J.1    Shimeall, W.T.2    Douglas, K.M.3    Shumway, N.M.4    O'Malley, P.G.5
  • 176
    • 0034605685 scopus 로고    scopus 로고
    • Treatment of warfarin-associated coagulopathy with oral Vitamin K: A randomised controlled trial
    • Crowther MA, Julian J, McCarty D, et al. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial. Lancet. 2000; 356(9241):1551-1553.
    • (2000) Lancet , vol.356 , Issue.9241 , pp. 1551-1553
    • Crowther, M.A.1    Julian, J.2    McCarty, D.3
  • 177
    • 23644461917 scopus 로고    scopus 로고
    • A randomized trial comparing 1 mg of oral Vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves
    • Ageno W, Garcia D, Silingardi M, Galli M, Crowther M. A randomized trial comparing 1 mg of oral vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves. J Am Coll Cardiol. 2005;46(4):732-733.
    • (2005) J Am Coll Cardiol , vol.46 , Issue.4 , pp. 732-733
    • Ageno, W.1    Garcia, D.2    Silingardi, M.3    Galli, M.4    Crowther, M.5
  • 178
    • 0035125371 scopus 로고    scopus 로고
    • Reversal of excessive oral anticoagulation with a low oral dose of vitamin K1 compared with acenocoumarine discontinuation. A prospective, randomized, open study
    • Fondevila CG, Grosso SH, Santarelli MT, Pinto MD. Reversal of excessive oral anticoagulation with a low oral dose of vitamin K1 compared with acenocoumarine discontinuation. A prospective, randomized, open study. Blood Coagul Fibrinolysis. 2001;12(1):9-16.
    • (2001) Blood Coagul Fibrinolysis , vol.12 , Issue.1 , pp. 9-16
    • Fondevila, C.G.1    Grosso, S.H.2    Santarelli, M.T.3    Pinto, M.D.4
  • 179
    • 61449121171 scopus 로고    scopus 로고
    • Oral Vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: A randomized trial
    • Crowther MA, Ageno W, Garcia D, et al. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med. 2009;150(5):293-300.
    • (2009) Ann Intern Med , vol.150 , Issue.5 , pp. 293-300
    • Crowther, M.A.1    Ageno, W.2    Garcia, D.3
  • 180
    • 0036313760 scopus 로고    scopus 로고
    • Low dose oral Vitamin K to reverse acenocoumarol-induced coagulopathy: A randomized controlled trial
    • Ageno W, Crowther M, Steidl L, et al. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial. Thromb Haemost. 2002;88(1):48-51.
    • (2002) Thromb Haemost , vol.88 , Issue.1 , pp. 48-51
    • Ageno, W.1    Crowther, M.2    Steidl, L.3
  • 181
    • 84892369024 scopus 로고    scopus 로고
    • Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose Vitamin K with genomic considerations: A pilot study
    • Bussey HI, Bussey M, Bussey-Smith KL, Frei CR. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study. Pharmacotherapy. 2013;33(11):1136-1146.
    • (2013) Pharmacotherapy , vol.33 , Issue.11 , pp. 1136-1146
    • Bussey, H.I.1    Bussey, M.2    Bussey-Smith, K.L.3    Frei, C.R.4
  • 182
    • 84994667137 scopus 로고    scopus 로고
    • Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis
    • Chai-Adisaksopha C, Hillis C, Siegal DM, et al. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. Thromb Haemost. 2016;116(5):879-890.
    • (2016) Thromb Haemost , vol.116 , Issue.5 , pp. 879-890
    • Chai-Adisaksopha, C.1    Hillis, C.2    Siegal, D.M.3
  • 183
    • 0032703196 scopus 로고    scopus 로고
    • Use of factor IX complex in warfarin-related intracranial hemorrhage
    • discussion 1118-1119
    • Boulis NM, Bobek MP, Schmaier A, Hoff JT. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery. 1999;45(5):1113-1118, discussion 1118-1119.
    • (1999) Neurosurgery , vol.45 , Issue.5 , pp. 1113-1118
    • Boulis, N.M.1    Bobek, M.P.2    Schmaier, A.3    Hoff, J.T.4
  • 184
    • 84884354180 scopus 로고    scopus 로고
    • Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on Vitamin K antagonists presenting with major bleeding: A randomized, plasma-controlled, phase IIIb study
    • Sarode R, Milling TJ Jr, Refaai MA, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128(11):1234-1243.
    • (2013) Circulation , vol.128 , Issue.11 , pp. 1234-1243
    • Sarode, R.1    Milling, T.J.2    Refaai, M.A.3
  • 185
    • 84962888094 scopus 로고    scopus 로고
    • Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to Vitamin K antagonists (INCH): A randomised trial
    • Steiner T, Poli S, Griebe M, et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol. 2016;15(6):566-573.
    • (2016) Lancet Neurol , vol.15 , Issue.6 , pp. 566-573
    • Steiner, T.1    Poli, S.2    Griebe, M.3
  • 186
    • 84952650861 scopus 로고    scopus 로고
    • 3-Factor versus 4-factor prothrombin complex concentrate for warfarin reversal in severe bleeding: A multicenter, retrospective, propensity-matched pilot study
    • Jones GM, Erdman MJ, Smetana KS, Mohrien KM, Vandigo JE, Elijovich L. 3-Factor versus 4-factor prothrombin complex concentrate for warfarin reversal in severe bleeding: a multicenter, retrospective, propensity-matched pilot study. J Thromb Thrombolysis. 2016;42(1):19-26.
    • (2016) J Thromb Thrombolysis , vol.42 , Issue.1 , pp. 19-26
    • Jones, G.M.1    Erdman, M.J.2    Smetana, K.S.3    Mohrien, K.M.4    Vandigo, J.E.5    Elijovich, L.6
  • 187
    • 79951836170 scopus 로고    scopus 로고
    • Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom
    • Guest JF, Watson HG, Limaye S. Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom. Clin Ther. 2010;32(14):2478-2493.
    • (2010) Clin Ther , vol.32 , Issue.14 , pp. 2478-2493
    • Guest, J.F.1    Watson, H.G.2    Limaye, S.3
  • 188
    • 85031283750 scopus 로고    scopus 로고
    • Management of rivaroxaban- Or apixaban-associated major bleeding with prothrombin complex concentrates: A cohort study
    • Majeed A, Ågren A, Holmström M, et al. Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study. Blood. 2017;130(15):1706-1712.
    • (2017) Blood , vol.130 , Issue.15 , pp. 1706-1712
    • Majeed, A.1    Ågren, A.2    Holmström, M.3
  • 189
    • 85010332908 scopus 로고    scopus 로고
    • Prothrombin complex concentrate administration for bleeding associated with non-Vitamin K antagonist oral anticoagulants: The SAMURAI-NVAF study
    • Yoshimura S, Sato S, Todo K, et al; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study Investigators. Prothrombin complex concentrate administration for bleeding associated with non-vitamin K antagonist oral anticoagulants: the SAMURAI-NVAF study. J Neurol Sci. 2017;375:150-157.
    • (2017) J Neurol Sci , vol.375 , pp. 150-157
    • Yoshimura, S.1    Sato, S.2    Todo, K.3
  • 190
    • 85040967783 scopus 로고    scopus 로고
    • Association of prothrombin complex concentrate administration and hematoma enlargement in non-Vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage
    • Gerner ST, Kuramatsu JB, Sembill JA, et al; RETRACE II (German-Wide Multicenter Analysis of Oral Anticoagulation-Associated Intracerebral Hemorrhage II) Investigators. Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage. Ann Neurol. 2018;83(1):186-196.
    • (2018) Ann Neurol , vol.83 , Issue.1 , pp. 186-196
    • Gerner, S.T.1    Kuramatsu, J.B.2    Sembill, J.A.3
  • 191
    • 84951752450 scopus 로고    scopus 로고
    • Administration of 4-factor prothrombin complex concentrate as an antidote for intracranial bleeding in patients taking direct factor Xa inhibitors
    • Grandhi R, Newman WC, Zhang X, et al. Administration of 4-factor prothrombin complex concentrate as an antidote for intracranial bleeding in patients taking direct factor Xa inhibitors. World Neurosurg. 2015;84(6):1956-1961.
    • (2015) World Neurosurg , vol.84 , Issue.6 , pp. 1956-1961
    • Grandhi, R.1    Newman, W.C.2    Zhang, X.3
  • 192
    • 85044317277 scopus 로고    scopus 로고
    • Prothrombin complex concentrate for major bleeding on factor Xa inhibitors: A prospective cohort study
    • Schulman S, Gross PL, Ritchie B, et al; Study Investigators. Prothrombin complex concentrate for major bleeding on factor Xa inhibitors: a prospective cohort study. Thromb Haemost. 2018;118(5):842-851.
    • (2018) Thromb Haemost , vol.118 , Issue.5 , pp. 842-851
    • Schulman, S.1    Gross, P.L.2    Ritchie, B.3
  • 193
    • 80052332326 scopus 로고    scopus 로고
    • Safety of prothrombin complex concentrates for rapid anticoagulation reversal of Vitamin K antagonists. A meta-analysis
    • Dentali F, Marchesi C, Giorgi Pierfranceschi M, et al. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost. 2011;106(3):429-438.
    • (2011) Thromb Haemost , vol.106 , Issue.3 , pp. 429-438
    • Dentali, F.1    Marchesi, C.2    Giorgi Pierfranceschi, M.3
  • 194
    • 84988893659 scopus 로고    scopus 로고
    • Andexanet alfa for acute major bleeding associated with factor Xa inhibitors
    • Connolly SJ, Milling TJ Jr, Eikelboom JW, et al; ANNEXA-4 Investigators. Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med. 2016;375(12):1131-1141.
    • (2016) N Engl J Med , vol.375 , Issue.12 , pp. 1131-1141
    • Connolly, S.J.1    Milling, T.J.2    Eikelboom, J.W.3
  • 195
    • 84938836381 scopus 로고    scopus 로고
    • Idarucizumab for dabigatran reversal
    • Pollack CV Jr, Reilly PA, Eikelboom J, et al. Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373(6):511-520.
    • (2015) N Engl J Med , vol.373 , Issue.6 , pp. 511-520
    • Pollack, C.V.1    Reilly, P.A.2    Eikelboom, J.3
  • 196
    • 84994107374 scopus 로고    scopus 로고
    • Idarucizumab as antidote to intracerebral hemorrhage under treatment with dabigatran
    • Held V, Eisele P, Eschenfelder CC, Szabo K. Idarucizumab as antidote to intracerebral hemorrhage under treatment with dabigatran. Case Rep Neurol. 2016;8(3):224-228.
    • (2016) Case Rep Neurol , vol.8 , Issue.3 , pp. 224-228
    • Held, V.1    Eisele, P.2    Eschenfelder, C.C.3    Szabo, K.4
  • 197
    • 85026815616 scopus 로고    scopus 로고
    • Idarucizumab for dabigatran reversal - Full cohort analysis
    • Pollack CV Jr, Reilly PA, van Ryn J, et al. Idarucizumab for dabigatran reversal - full cohort analysis. N Engl J Med. 2017;377(5):431-441.
    • (2017) N Engl J Med , vol.377 , Issue.5 , pp. 431-441
    • Pollack, C.V.1    Reilly, P.A.2    Van Ryn, J.3
  • 198
    • 80053375761 scopus 로고    scopus 로고
    • Safety and benefits of protamine administration to revert anticoagulation soon after coronary angioplasty. A meta-analysis
    • De Luca G, Parodi G, Antoniucci D. Safety and benefits of protamine administration to revert anticoagulation soon after coronary angioplasty. A meta-analysis. J Thromb Thrombolysis. 2010;30(4):452-458.
    • (2010) J Thromb Thrombolysis , vol.30 , Issue.4 , pp. 452-458
    • De Luca, G.1    Parodi, G.2    Antoniucci, D.3
  • 199
    • 84961794749 scopus 로고    scopus 로고
    • Use of protamine for anticoagulation during carotid endarterectomy: A meta-analysis
    • Newhall KA, Saunders EC, Larson RJ, Stone DH, Goodney PP. Use of protamine for anticoagulation during carotid endarterectomy: a meta-analysis. JAMA Surg. 2016;151(3):247-255.
    • (2016) JAMA Surg , vol.151 , Issue.3 , pp. 247-255
    • Newhall, K.A.1    Saunders, E.C.2    Larson, R.J.3    Stone, D.H.4    Goodney, P.P.5
  • 201
    • 0342460483 scopus 로고    scopus 로고
    • In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation
    • Pan M, Suárez de Lezo J, Medina A, et al. In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. Am J Cardiol. 1997;80(10):1336-1338.
    • (1997) Am J Cardiol , vol.80 , Issue.10 , pp. 1336-1338
    • Pan, M.1    Suárez De Lezo, J.2    Medina, A.3
  • 202
    • 26044432296 scopus 로고    scopus 로고
    • Impact of heparin neutralization by protamine on restenosis after coronary stent implantation
    • Kaneda H, Suzuki J, Hosokawa G, Tanaka S, Hiroe Y, Saito S. Impact of heparin neutralization by protamine on restenosis after coronary stent implantation. Int J Cardiol. 2005;105(1):111-112.
    • (2005) Int J Cardiol , vol.105 , Issue.1 , pp. 111-112
    • Kaneda, H.1    Suzuki, J.2    Hosokawa, G.3    Tanaka, S.4    Hiroe, Y.5    Saito, S.6
  • 203
    • 0029083373 scopus 로고
    • Stroke rate is markedly reduced after carotid endarterectomy by avoidance of protamine
    • discussion 269-270
    • Mauney MC, Buchanan SA, Lawrence WA, et al. Stroke rate is markedly reduced after carotid endarterectomy by avoidance of protamine. J Vasc Surg. 1995;22(3):264-269, discussion 269-270.
    • (1995) J Vasc Surg , vol.22 , Issue.3 , pp. 264-269
    • Mauney, M.C.1    Buchanan, S.A.2    Lawrence, W.A.3
  • 204
    • 0032912642 scopus 로고    scopus 로고
    • Relationship of protamine dosing with postoperative complications of carotid endarterectomy
    • Levison JA, Faust GR, Halpern VJ, et al. Relationship of protamine dosing with postoperative complications of carotid endarterectomy. Ann Vasc Surg. 1999;13(1):67-72.
    • (1999) Ann Vasc Surg , vol.13 , Issue.1 , pp. 67-72
    • Levison, J.A.1    Faust, G.R.2    Halpern, V.J.3
  • 205
    • 45749092546 scopus 로고    scopus 로고
    • Is heparin reversal with protamine after carotid endarterectomy dangerous?
    • Dellagrammaticas D, Lewis SC, Gough MJ; GALA Trial Collaborators. Is heparin reversal with protamine after carotid endarterectomy dangerous? Eur J Vasc Endovasc Surg. 2008;36(1):41-44.
    • (2008) Eur J Vasc Endovasc Surg , vol.36 , Issue.1 , pp. 41-44
    • Dellagrammaticas, D.1    Lewis, S.C.2    Gough, M.J.3
  • 206
    • 77549085704 scopus 로고    scopus 로고
    • Protamine reduces bleeding complications associated with carotid endarterectomy without increasing the risk of stroke
    • Stone DH, Nolan BW, Schanzer A, et al. Protamine reduces bleeding complications associated with carotid endarterectomy without increasing the risk of stroke. J Vasc Surg. 2010;51(3):559-564.
    • (2010) J Vasc Surg , vol.51 , Issue.3 , pp. 559-564
    • Stone, D.H.1    Nolan, B.W.2    Schanzer, A.3
  • 207
    • 84898926500 scopus 로고    scopus 로고
    • Using protamine can significantly reduce the incidence of bleeding complications after carotid endarterectomy without increasing the risk of ischemic cerebral events
    • Mazzalai F, Piatto G, Toniato A, Lorenzetti R, Baracchini C, Ballotta E. Using protamine can significantly reduce the incidence of bleeding complications after carotid endarterectomy without increasing the risk of ischemic cerebral events. World J Surg. 2014;38(5):1227-1232.
    • (2014) World J Surg , vol.38 , Issue.5 , pp. 1227-1232
    • Mazzalai, F.1    Piatto, G.2    Toniato, A.3    Lorenzetti, R.4    Baracchini, C.5    Ballotta, E.6
  • 209
    • 0025087349 scopus 로고
    • The influence of neutralizing heparin after carotid endarterectomy on postoperative stroke and wound hematoma
    • discussion 445-446
    • Treiman RL, Cossman DV, Foran RF, Levin PM, Cohen JL, Wagner WH. The influence of neutralizing heparin after carotid endarterectomy on postoperative stroke and wound hematoma. J Vasc Surg. 1990;12(4):440-445, discussion 445-446.
    • (1990) J Vasc Surg , vol.12 , Issue.4 , pp. 440-445
    • Treiman, R.L.1    Cossman, D.V.2    Foran, R.F.3    Levin, P.M.4    Cohen, J.L.5    Wagner, W.H.6
  • 210
    • 0031267440 scopus 로고    scopus 로고
    • Risk factors of stroke in carotid endarterectomy [in Portuguese]
    • Salles LR, Puech-Leão P, Netto BM, et al. Risk factors of stroke in carotid endarterectomy [in Portuguese]. Rev Hosp Clin Fac Med Sao Paulo. 1997; 52(6):291-294.
    • (1997) Rev Hosp Clin Fac Med Sao Paulo , vol.52 , Issue.6 , pp. 291-294
    • Salles, L.R.1    Puech-Leão, P.2    Netto, B.M.3
  • 211
    • 84884472471 scopus 로고    scopus 로고
    • Clinical observation of neutralizing heparin with protamine in carotid endarterectomy [in Chinese]
    • Liu Q, Chen YX, Ni L, Chen Y, Liu CW. Clinical observation of neutralizing heparin with protamine in carotid endarterectomy [in Chinese]. Zhonghua Yi Xue Za Zhi. 2013;93(33):2650-2653.
    • (2013) Zhonghua Yi Xue Za Zhi , vol.93 , Issue.33 , pp. 2650-2653
    • Liu, Q.1    Chen, Y.X.2    Ni, L.3    Chen, Y.4    Liu, C.W.5
  • 212
    • 46749116379 scopus 로고    scopus 로고
    • In-laboratory femoral sheath removal after heparin reversal by protamine after percutaneous coronary intervention
    • Thuesen L, Andersen HR, Bøtker HE, Dalby Kristensen S, Krusell LR, Lassen JF. In-laboratory femoral sheath removal after heparin reversal by protamine after percutaneous coronary intervention. EuroIntervention. 2005;1(1):66-69.
    • (2005) EuroIntervention , vol.1 , Issue.1 , pp. 66-69
    • Thuesen, L.1    Andersen, H.R.2    Bøtker, H.E.3    Dalby Kristensen, S.4    Krusell, L.R.5    Lassen, J.F.6
  • 213
    • 34548613694 scopus 로고    scopus 로고
    • Immediate removal of femoral-sheath following protamine administration in patients undergoing intracoronary paclitaxel-eluting-stent implantation
    • Rossi ML, Zavalloni D, Scatturin M, Gasparini GL, Lisignoli V, Presbitero P. Immediate removal of femoral-sheath following protamine administration in patients undergoing intracoronary paclitaxel-eluting-stent implantation. Expert Opin Pharmacother. 2007;8(13):2017-2024.
    • (2007) Expert Opin Pharmacother , vol.8 , Issue.13 , pp. 2017-2024
    • Rossi, M.L.1    Zavalloni, D.2    Scatturin, M.3    Gasparini, G.L.4    Lisignoli, V.5    Presbitero, P.6
  • 214
    • 84879926774 scopus 로고    scopus 로고
    • Protamine does not increase risk of stroke in patients with elective carotid stenting
    • McDonald JS, Kallmes DF, Lanzino G, Cloft HJ. Protamine does not increase risk of stroke in patients with elective carotid stenting. Stroke. 2013;44(7): 2028-2030.
    • (2013) Stroke , vol.44 , Issue.7 , pp. 2028-2030
    • McDonald, J.S.1    Kallmes, D.F.2    Lanzino, G.3    Cloft, H.J.4
  • 215
    • 0024696509 scopus 로고
    • Cervical wound hematoma after carotid endarterectomy
    • Welling RE, Ramadas HS, Gansmuller KJ. Cervical wound hematoma after carotid endarterectomy. Ann Vasc Surg. 1989;3(3):229-231.
    • (1989) Ann Vasc Surg , vol.3 , Issue.3 , pp. 229-231
    • Welling, R.E.1    Ramadas, H.S.2    Gansmuller, K.J.3
  • 216
    • 84943189471 scopus 로고    scopus 로고
    • Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysis
    • Chai-Adisaksopha C, Hillis C, Monreal M, Witt DM, Crowther M. Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysis. Thromb Haemost. 2015;114(4):819-825.
    • (2015) Thromb Haemost , vol.114 , Issue.4 , pp. 819-825
    • Chai-Adisaksopha, C.1    Hillis, C.2    Monreal, M.3    Witt, D.M.4    Crowther, M.5
  • 217
    • 84902200009 scopus 로고    scopus 로고
    • Gastrointestinal hemorrhage in warfarin anticoagulated patients: Incidence, risk factor, management, and outcome
    • Chen WC, Chen YH, Hsu PI, et al. Gastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcome. BioMed Res Int. 2014;2014:463767.
    • (2014) BioMed Res Int , vol.2014 , pp. 463767
    • Chen, W.C.1    Chen, Y.H.2    Hsu, P.I.3
  • 218
    • 54049102857 scopus 로고    scopus 로고
    • Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage
    • Claassen DO, Kazemi N, Zubkov AY, Wijdicks EF, Rabinstein AA. Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage. Arch Neurol. 2008;65(10):1313-1318.
    • (2008) Arch Neurol , vol.65 , Issue.10 , pp. 1313-1318
    • Claassen, D.O.1    Kazemi, N.2    Zubkov, A.Y.3    Wijdicks, E.F.4    Rabinstein, A.A.5
  • 219
    • 84880974900 scopus 로고    scopus 로고
    • Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy
    • Gathier CS, Algra A, Rinkel GJ, van der Worp HB. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy. Cerebrovasc Dis. 2013;36(1):33-37.
    • (2013) Cerebrovasc Dis , vol.36 , Issue.1 , pp. 33-37
    • Gathier, C.S.1    Algra, A.2    Rinkel, G.J.3    Van Der Worp, H.B.4
  • 220
    • 84975126991 scopus 로고    scopus 로고
    • Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: A retrospective cohort study
    • Guha D, Coyne S, Macdonald RL. Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: a retrospective cohort study. J Neurosurg. 2016;124(3):750-759.
    • (2016) J Neurosurg , vol.124 , Issue.3 , pp. 750-759
    • Guha, D.1    Coyne, S.2    Macdonald, R.L.3
  • 221
    • 85002062845 scopus 로고    scopus 로고
    • Anticoagulation use and clinical outcomes after major bleeding on dabigatran or warfarin in atrial fibrillation
    • Hernandez I, Zhang Y, Brooks MM, Chin PK, Saba S. Anticoagulation use and clinical outcomes after major bleeding on dabigatran or warfarin in atrial fibrillation. Stroke. 2017;48(1):159-166.
    • (2017) Stroke , vol.48 , Issue.1 , pp. 159-166
    • Hernandez, I.1    Zhang, Y.2    Brooks, M.M.3    Chin, P.K.4    Saba, S.5
  • 222
    • 85014222847 scopus 로고    scopus 로고
    • Optimal timing of Vitamin K antagonist resumption after upper gastrointestinal bleeding. A risk modelling analysis
    • Majeed A, Wallvik N, Eriksson J, et al. Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding. A risk modelling analysis. Thromb Haemost. 2017;117(3):491-499.
    • (2017) Thromb Haemost , vol.117 , Issue.3 , pp. 491-499
    • Majeed, A.1    Wallvik, N.2    Eriksson, J.3
  • 224
    • 85018548785 scopus 로고    scopus 로고
    • Outcomes associated with resuming warfarin treatment after hemorrhagic stroke or traumatic intracranial hemorrhage in patients with atrial fibrillation
    • Nielsen PB, Larsen TB, Skjøth F, Lip GY. Outcomes associated with resuming warfarin treatment after hemorrhagic stroke or traumatic intracranial hemorrhage in patients with atrial fibrillation. JAMA Intern Med. 2017;177(4):563-570.
    • (2017) JAMA Intern Med , vol.177 , Issue.4 , pp. 563-570
    • Nielsen, P.B.1    Larsen, T.B.2    Skjøth, F.3    Lip, G.Y.4
  • 225
    • 84949657450 scopus 로고    scopus 로고
    • A multicenter, prospective, observational study of warfarin-associated intracerebral hemorrhage: The SAMURAI-WAICH study
    • Osaki M, Koga M, Maeda K, et al; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement Study Investigators. A multicenter, prospective, observational study of warfarin-associated intracerebral hemorrhage: the SAMURAI-WAICH study. J Neurol Sci. 2015;359(1-2):72-77.
    • (2015) J Neurol Sci , vol.359 , Issue.1-2 , pp. 72-77
    • Osaki, M.1    Koga, M.2    Maeda, K.3
  • 226
    • 84895069540 scopus 로고    scopus 로고
    • Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation
    • published correction Am J Cardiol. 2015;116(1):166
    • Qureshi W, Mittal C, Patsias I, et al. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation [published correction appears in Am J Cardiol. 2015;116(1):166]. Am J Cardiol. 2014;113(4):662-668.
    • (2014) Am J Cardiol , vol.113 , Issue.4 , pp. 662-668
    • Qureshi, W.1    Mittal, C.2    Patsias, I.3
  • 227
    • 84922267371 scopus 로고    scopus 로고
    • The risks of thromboembolism vs. Recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: A prospective study
    • published correction Am J Gastroenterol. 2015; 110(3):480
    • Sengupta N, Feuerstein JD, Patwardhan VR, et al. The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study [published correction appears in Am J Gastroenterol. 2015; 110(3):480]. Am J Gastroenterol. 2015;110(2):328-335.
    • (2015) Am J Gastroenterol , vol.110 , Issue.2 , pp. 328-335
    • Sengupta, N.1    Feuerstein, J.D.2    Patwardhan, V.R.3
  • 228
    • 84893005960 scopus 로고    scopus 로고
    • Warfarin associated intracerebral hemorrhage in Hong Kong Chinese
    • Teo KC, Mahboobani NR, Lee R, et al. Warfarin associated intracerebral hemorrhage in Hong Kong Chinese. Neurol Res. 2014;36(2):143-149.
    • (2014) Neurol Res , vol.36 , Issue.2 , pp. 143-149
    • Teo, K.C.1    Mahboobani, N.R.2    Lee, R.3
  • 229
    • 84948701464 scopus 로고    scopus 로고
    • Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage
    • Witt DM, Clark NP, Martinez K, et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage. Thromb Res. 2015;136(5):1040-1044.
    • (2015) Thromb Res , vol.136 , Issue.5 , pp. 1040-1044
    • Witt, D.M.1    Clark, N.P.2    Martinez, K.3
  • 230
    • 84868276151 scopus 로고    scopus 로고
    • Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding
    • Witt DM, Delate T, Garcia DA, et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med. 2012;172(19):1484-1491.
    • (2012) Arch Intern Med , vol.172 , Issue.19 , pp. 1484-1491
    • Witt, D.M.1    Delate, T.2    Garcia, D.A.3
  • 231
    • 84923314908 scopus 로고    scopus 로고
    • Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage
    • Kuramatsu JB, Gerner ST, Schellinger PD, et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA. 2015;313(8):824-836.
    • (2015) JAMA , vol.313 , Issue.8 , pp. 824-836
    • Kuramatsu, J.B.1    Gerner, S.T.2    Schellinger, P.D.3
  • 232
    • 78650416405 scopus 로고    scopus 로고
    • Optimal timing of resumption of warfarin after intracranial hemorrhage
    • Majeed A, Kim YK, Roberts RS, Holmström M, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke. 2010;41(12): 2860-2866.
    • (2010) Stroke , vol.41 , Issue.12 , pp. 2860-2866
    • Majeed, A.1    Kim, Y.K.2    Roberts, R.S.3    Holmström, M.4    Schulman, S.5
  • 233
    • 84856024245 scopus 로고    scopus 로고
    • Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: The Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study
    • Yung D, Kapral MK, Asllani E, Fang J, Lee DS; Investigators of the Registry of the Canadian Stroke Network. Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study. Can J Cardiol. 2012;28(1):33-39.
    • (2012) Can J Cardiol , vol.28 , Issue.1 , pp. 33-39
    • Yung, D.1    Kapral, M.K.2    Asllani, E.3    Fang, J.4    Lee, D.S.5
  • 234
    • 84856772158 scopus 로고    scopus 로고
    • Evidence-based management of anticoagulant therapy: Antithrombotic therapy and Prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
    • Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(suppl 2):e152S-e184S.
    • (2012) Chest , vol.141 , pp. e152S-e184S
    • Holbrook, A.1    Schulman, S.2    Witt, D.M.3
  • 235
    • 85009227704 scopus 로고    scopus 로고
    • GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: Grade-adolopment
    • Schünemann HJ, Wiercioch W, Brozek J, et al. GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. J Clin Epidemiol. 2017;81:101-110.
    • (2017) J Clin Epidemiol , vol.81 , pp. 101-110
    • Schünemann, H.J.1    Wiercioch, W.2    Brozek, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.